var title_f29_3_29744="Erythema marginatum on trunk";
var content_f29_3_29744=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F50841&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F50841&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema marginatum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 291px; height: 335px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This image of the back of a patient with acute rheumatic fever shows the characteristic rash, erythema marginatum. Note the erythematous lesions with pale centers and rounded or serpiginous margins.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Binotto, MA, Guilherme, L, Tanaka, AC. Rheumatic fever. Images Paediatr Cardiol 2002; 11:12. Copyright &copy; 2002 Images in Paediatric Cardiology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29744=[""].join("\n");
var outline_f29_3_29744=null;
var title_f29_3_29745="Patient information: Stillbirth (The Basics)";
var content_f29_3_29745=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/82987\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"UTD.htm?9/8/9355\">",
"         Support groups for stillbirth",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Stillbirth (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/stillbirth-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H13954649\">",
"      <span class=\"h1\">",
"       What is stillbirth?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A stillbirth is when a baby dies before it is born, in the second half of pregnancy (after 20 weeks).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13954664\">",
"      <span class=\"h1\">",
"       What causes stillbirth?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There are many reasons a stillbirth can happen. Some of them include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Problems with the placenta &ndash; The placenta is the organ inside the uterus that brings a baby nutrients and oxygen. One problem that can happen with the placenta is called an &ldquo;abruption&rdquo; (also called &ldquo;abruptio placenta&rdquo;). This is when the placenta pulls away or separates from the uterus before the baby is born. Another problem might be a placenta that doesn&rsquo;t give the baby enough nutrients or oxygen. When this happens, the baby grows slowly and is very small.",
"       </li>",
"       <li>",
"        Problems with the baby &ndash; This could include birth defects or an infection.",
"       </li>",
"       <li>",
"        Serious medical conditions in the mother &ndash; These include poorly controlled diabetes, kidney disease, or high blood pressure.",
"       </li>",
"       <li>",
"        Problems with the umbilical cord - In rare cases, problems with the umbilical cord cause stillbirth. For example, there can be a knot in the cord.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In about one third of stillbirths, doctors do not know why the stillbirth happened.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13954679\">",
"      <span class=\"h1\">",
"       What are the symptoms of a stillbirth?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The main symptom of stillbirth is",
"     </p>",
"     <p>",
"      not being able to feel the baby moving inside you.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13954694\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you don&rsquo;t feel the baby moving, your doctor or nurse will check for the baby&rsquo;s heartbeat and might do an ultrasound. If there is no heartbeat on the ultrasound, it means the baby has died.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13954711\">",
"      <span class=\"h1\">",
"       What happens next?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your baby has died inside the womb, your doctor or nurse will probably ask if you want labor &ldquo;induced.&rdquo; That means that you will get medicines to start contractions, so you will have your baby in the next few days.",
"     </p>",
"     <p>",
"      Some women prefer to wait until labor starts on its own, which usually happens 1 to 2 weeks after a fetus dies. But sometimes it is not safe to wait. Rarely, women need to have a &ldquo;C-section,&rdquo; which is surgery to get the baby out.",
"     </p>",
"     <p>",
"      After the baby is delivered, the doctor will do tests to try to find out why the stillbirth happened.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13954726\">",
"      <span class=\"h1\">",
"       Will I be able to have a normal pregnancy after a stillbirth?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Probably. Most women who have a stillbirth go on to have healthy pregnancies. But you should talk about the risk of stillbirth with your doctor or nurse before trying to get pregnant again.",
"     </p>",
"     <p>",
"      Your doctor might suggest that you wait several months before trying to get pregnant again. Before you start trying to get pregnant, see your doctor nurse. He or she can help make sure you are as healthy as possible before and during any future pregnancies.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13954743\">",
"      <span class=\"h1\">",
"       How do we cope with the loss of the baby?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It is normal to grieve the loss of the baby. What was a joyful time is now sad, confusing, and stressful. People react to the loss in different ways.",
"     </p>",
"     <p>",
"      The people on your healthcare team will do what they can to help you cope. Your doctor will probably suggest that you talk to a counselor. Talking helps many people get through this difficult time.",
"     </p>",
"     <p>",
"      Support groups might be helpful for some people. Support groups are groups of people who have gone through a loss such as yours and who get together to talk about their feelings. Your doctor, nurse or counselor can help you find a support group if you would like to join one (",
"      <a class=\"graphic graphic_table graphicRef82797 \" href=\"UTD.htm?9/8/9355\">",
"       table 1",
"      </a>",
"      ).",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?29/3/29745?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82987 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-47BF19C4B0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29745=[""].join("\n");
var outline_f29_3_29745=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954649\">",
"      What is stillbirth?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954664\">",
"      What causes stillbirth?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954679\">",
"      What are the symptoms of a stillbirth?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954694\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954711\">",
"      What happens next?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954726\">",
"      Will I be able to have a normal pregnancy after a stillbirth?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13954743\">",
"      How do we cope with the loss of the baby?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/82987\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/8/9355\">",
"      Support groups for stillbirth",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_3_29746="Steroid atrophy post injection";
var content_f29_3_29746=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F50142&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F50142&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Steroid atrophy and loss of pigmentation from intralesional steroid therapy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These effects are usually temporary and self-resolving, but in this instance the result was permanent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Mosby, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29746=[""].join("\n");
var outline_f29_3_29746=null;
var title_f29_3_29747="Local and systemic distribution of ICS";
var content_f29_3_29747=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59553&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59553&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pharmacokinetics of inhaled corticosteroids",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 307px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Eighty to 90 percent of the corticosteroid dose from a metered dose inhaler is swallowed and absorbed from the gastrointestinal tract. This fraction is then largely metabolized by the liver (\"first pass metabolism\") so that only a small amount is absorbed into the systemic circulation. Approximately 10 to 20 percent of a dose of corticosteroid from a metered dose inhaler is delivered to the respiratory tract. This is absorbed from the lung periphery directly into the systemic circulation. Thus, although less of the dose is delivered to the respiratory tract, that is the amount that contributes proportionately more to systemic side effects.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29747=[""].join("\n");
var outline_f29_3_29747=null;
var title_f29_3_29748="Darier disease - dark skin";
var content_f29_3_29748=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F70000&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F70000&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Darier diseae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple hyperpigmented, hyperkeratotic papules are on the chest.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29748=[""].join("\n");
var outline_f29_3_29748=null;
var title_f29_3_29749="Perianal fistula Crohns";
var content_f29_3_29749=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F78460&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F78460&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Perianal fistula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 373px; height: 274px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Perianal fistula in a patient with Crohn's disease. Scarring and deformity from previous fistulas is also apparent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David A Schwartz, MD and Maurits J Wiersema, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29749=[""].join("\n");
var outline_f29_3_29749=null;
var title_f29_3_29750="Ampicillin and sulbactam: Pediatric drug information";
var content_f29_3_29750=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ampicillin and sulbactam: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1160?source=see_link\">",
"    see \"Ampicillin and sulbactam: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?35/3/35891?source=see_link\">",
"    see \"Ampicillin and sulbactam: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F135090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Unasyn&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F135091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Unasyn&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1045193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Beta-lactam and Beta-lactamase Combination",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Penicillin",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F13361887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Unasyn&reg; (ampicillin/sulbactam) is a combination product formulated in a 2:1 ratio (eg, each 3 g vial contains 2 g of ampicillin and 1 g of sulbactam); review dosing units carefully. Dosage recommendations are expressed as mg of the",
"     <b>",
"      ampicillin",
"     </b>",
"     component.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Susceptible infection (non-CNS), treatment:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Premature neonate: 100 mg/kg/day divided every 12 hours; dosing based on a pharmacokinetic analysis of 15 premature neonates using a 1:1 formulation of ampicillin to sulbactam (GA &le;28 weeks: n=6; GA &gt;28 weeks: n=9) (Sutton, 1986)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Full-term neonate: 100 mg/kg/day divided every 8 hours for &le;8 days was used in 108 neonates (GA &ge;37 weeks) (Manzoni, 2009)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1045186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1160?source=see_link\">",
"      see \"Ampicillin and sulbactam: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Unasyn&reg; (ampicillin/sulbactam) is a combination product formulated in a 2:1 ratio (eg, each 3 g vial contains 2 g of ampicillin and 1 g of sulbactam); review dosing units carefully.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Infants, Children, and Adolescents (&ge;1 month and  &lt;40 kg):",
"     <b>",
"      Note:",
"     </b>",
"     Dosage recommendations are expressed as mg of the",
"     <b>",
"      ampicillin",
"     </b>",
"     component. Maximum daily dose: 8000 mg/",
"     <b>",
"      day",
"     </b>",
"     ampicillin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      General dosing:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Mild to moderate infection: I.V.: 100-150 mg ampicillin/kg/day divided every 6 hours (",
"     <i>",
"      Red Book",
"     </i>",
"     , 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Severe infection: I.V.: 200-400 mg ampicillin/kg/day divided every 6 hours (",
"     <i>",
"      Red Book",
"     </i>",
"     , 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Manufacturer&rsquo;s labeling: Children &ge;1 year and Adolescents &lt;40 kg: 200 mg/kg/day divided every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Endocarditis, treatment:",
"     </b>",
"     I.V.: 200 mg ampicillin/kg/day divided every 4-6 hours with gentamicin (optional) for at least 4-6 weeks; some organisms may require longer duration (Baddour, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Intra-abdominal infection:",
"     </b>",
"     I.V.: 200 mg/kg/day divided every 6 hours;",
"     <b>",
"      Note:",
"     </b>",
"     Due to high rates of",
"     <i>",
"      E. coli",
"     </i>",
"     resistance, not recommended for the treatment of community-acquired intra-abdominal infections (Solomkin, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Meningitis:",
"     </b>",
"     I.V.: 200-400 mg ampicillin/kg/day divided every 6 hours (",
"     <i>",
"      Red Book",
"     </i>",
"     , 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Skin, soft tissue infection:",
"     </b>",
"     I.V.: 200 mg ampicillin/kg/day divided every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &ge;40 kg, Adolescents &ge;40 kg, and Adults:",
"     <b>",
"      Note:",
"     </b>",
"     Doses expressed as grams of the",
"     <b>",
"      ampicillin/sulbactam combination",
"     </b>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      General dosing:",
"     </b>",
"     I.M., I.V.: 1.5-3 g every 6 hours (maximum daily dose: Unasyn&reg; 12 g/",
"     <b>",
"      day",
"     </b>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Amnionitis, cholangitis, diverticulitis, endometritis, endophthalmitis, epididymitis/orchitis, liver abscess, osteomyelitis (diabetic foot), peritonitis:",
"     </b>",
"     I.V.: 3 g every 6 hours;",
"     <b>",
"      Note:",
"     </b>",
"     Due to high rates of",
"     <i>",
"      E. coli",
"     </i>",
"     resistance, not recommended for the treatment of community-acquired intra-abdominal infections (Solomkin, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Endocarditis:",
"     </b>",
"     I.V.: 3 g every 6 hours with gentamicin for 4-6 weeks (Baddour, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      <i>",
"       Pasteurella multocida",
"      </i>",
"      (human, canine/feline bites):",
"     </b>",
"     I.V.: 1.5-3 g every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Pelvic inflammatory disease:",
"     </b>",
"     I.V.: 3 g every 6 hours with doxycycline (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Peritonitis (CAPD):",
"     </b>",
"     Intraperitoneal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Anuric, intermittent: 3 g every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Anuric, continuous: Loading dose: 1.5 g per liter of dialysate; maintenance dose: 150 mg per liter",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Pneumonia:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Aspiration, community-acquired: I.V.: 1.5-3 g every 6 hours (Mandell, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Hospital-acquired: I.V.: 3 g every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Urinary tract infections, pyelonephritis:",
"     </b>",
"     I.V.: 3 g every 6 hours for 14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing interval in renal impairment:",
"     </b>",
"     Children and Adults:",
"     <b>",
"      Note:",
"     </b>",
"     Doses expressed as",
"     <b>",
"      ampicillin/sulbactam combination",
"     </b>",
"     . I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     15-29 mL/minute/1.73m",
"     <sup>",
"      2",
"     </sup>",
"     : Administer every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     5-14 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     : Administer every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Intermittent hemodialysis (IHD): Adults: 1.5-3 g  every 12-24 hours (administer after hemodialysis on dialysis days) (Heintz, 2009).",
"     <b>",
"      Note:",
"     </b>",
"     Dosing dependent on the assumption of 3 times/week, complete IHD sessions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Peritoneal dialysis (PD): Adults: 3 g every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Continuous renal replacement therapy (CRRT): Adults: Drug clearance is highly dependent on the method of renal replacement, filter type, and flow rate. Appropriate dosing requires close monitoring of pharmacologic response, signs of adverse reactions due to drug accumulation, as well as drug concentrations in relation to target trough (if appropriate). The following are general recommendations only (based on dialysate flow/ultrafiltration rates of 1-2 L/hour and minimal residual renal function) and should not supersede clinical judgment (Heintz, 2009; Trotman, 2005):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     CVVH: Initial: 3 g; maintenance: 1.5-3 g every 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     CVVHD: Initial: 3 g; maintenance: 1.5-3 g every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     CVVHDF: Initial: 3 g; maintenance: 1.5-3 g every 6-8 hours",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F135070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution: 1.5 g: Ampicillin 1 g and sulbactam 0.5 g; 3 g: Ampicillin 2 g and sulbactam 1 g; 15 g: Ampicillin 10 g and sulbactam 5 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Unasyn&reg;:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     1.5 g: Ampicillin 1 g and sulbactam 0.5 g [contains sodium 115 mg (5 mEq)/1.5 g)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     3 g: Ampicillin 2 g and sulbactam 1 g [contains sodium 115 mg (5 mEq)/1.5 g)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     15 g: Ampicillin 10 g and sulbactam 5 g [bulk package; contains sodium 115 mg (5 mEq)/1.5 g)]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F135054\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1045196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.M.: For use in adults patients only; reconstitute with SWI or lidocaine (0.5% or 2%) to a final concentration of 375 mg/mL of Unasyn&reg; (ie, 250 mg/mL of ampicillin and 125 mg/mL of sulbactam); administer by deep I.M. injection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V.: Administered by slow I.V. injection over 10-15 minutes or by intermittent I.V. infusion over 15-30 minutes; final concentration should not exceed 45 mg/mL Unasyn&reg; (30 mg/mL of  ampicillin and 15 mg/mL of sulbactam)",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F135118\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS;",
"     <b>",
"      variable stability (consult detailed reference)",
"     </b>",
"     in D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Amifostine, anidulafungin, aztreonam, bivalirudin, cefepime, dexmedetomidine, docetaxel, enalaprilat, etoposide phosphate, famotidine, fenoldopam, filgrastim, fluconazole, fludarabine, gallium, gemcitabine, granisetron, heparin, hetastarch in lactate electrolyte injection (Hextend&reg;), insulin (regular), linezolid, meperidine, morphine, paclitaxel, palonosetron, pemetrexed, remifentanil, tacrolimus, teniposide, theophylline, thiotepa.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Aminoglycosides (gentamicin, tobramycin), amiodarone, amphotericin B cholesteryl sulfate complex, ciprofloxacin, idarubicin, nicardipine, ondansetron.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Cisatracurium, diltiazem, sargramostim, vancomycin.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1045190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store intact vials at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); incompatible with aminoglycosides",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.M.: Concentration of 250 mg ampicillin/mL should be used 1 hour after preparation with SWI or lidocaine (0.5% or 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Intermittent I.V. infusion: Solutions further diluted in NS are stable up to 72 hours (20 mg ampicillin/mL) under refrigeration (4&deg;C) compared to dextrose solutions (at same concentrations) which are stable for only 4 hours",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1045195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of susceptible bacterial infections involved with skin and skin structure (FDA approved in ages &ge;1 year and adults); treatment of susceptible bacterial intra-abdominal infections and gynecological infections (FDA approved in adults); spectrum is that of ampicillin plus organisms producing beta-lactamases such as",
"     <i>",
"      Staphylococcus",
"     </i>",
"     sp,",
"     <i>",
"      Streptococcus",
"     </i>",
"     sp,",
"     <i>",
"      H. influenzae",
"     </i>",
"     ,",
"     <i>",
"      E. coli",
"     </i>",
"     ,",
"     <i>",
"      K. pneumonia",
"     </i>",
"     ,",
"     <i>",
"      Proteus",
"     </i>",
"     sp (including",
"     <i>",
"      P. mirabilis",
"     </i>",
"     ),",
"     <i>",
"      Acinetobacter calcoaceticus",
"     </i>",
"     ,",
"     <i>",
"      Providencia rettgeri",
"     </i>",
"     ,",
"     <i>",
"      Providencia stuartii",
"     </i>",
"     ,",
"     <i>",
"      Morganella morganii",
"     </i>",
"     ,",
"     <i>",
"      Neisseria gonorrhoeae",
"     </i>",
"     ,",
"     <i>",
"      Enterobacter",
"     </i>",
"     sp, and anaerobes (including",
"     <i>",
"      B. fragilis, P. multocida",
"     </i>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F135117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Also see Ampicillin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Pain at injection site (I.M./I.V.), thrombophlebitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction (may include serum sickness, urticaria, bronchospasm, hypotension, etc)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Abdominal distension, agranulocytosis, anemia, atypical lymphocytosis, candidiasis, chest pain, chills, dysuria, edema, epistaxis, erythema, facial swelling, fatigue, flatulence, gastritis, glossitis, hairy tongue, headache, interstitial nephritis, itching, leukopenia, liver enzymes increased, malaise, mucosal bleeding, nausea, pseudomembranous colitis, seizure, stomatitis, substernal pain, throat tightness, thrombocytopenia, urine retention, vomiting",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1045199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to ampicillin, sulbactam, any component, or penicillins",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1045185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with renal impairment; dosage adjustment recommended; use with caution in patients allergic to cephalosporins and asthmatic patients. Some penicillins (eg, carbenicillin, ticarcillin, and piperacillin) have been shown to inactivate aminoglycosides",
"     <i>",
"      in vitro",
"     </i>",
"     . This has been observed to a greater extent with tobramycin and gentamicin, while amikacin has shown greater stability against inactivation. Concomitant use of these agents may pose a risk of reduced antibacterial efficacy",
"     <i>",
"      in vivo",
"     </i>",
"     , particularly in the setting of profound renal impairment; however, definitive clinical evidence is lacking. If combination penicillin/aminoglycoside therapy is desired in a patient with renal dysfunction, separation of doses (if feasible), and routine monitoring of aminoglycoside concentrations, CBC, and clinical response should be considered.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1045184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serious and occasionally fatal hypersensitivity (anaphylactoid) reactions have been reported in patients on penicillin therapy, especially with a history of beta-lactam hypersensitivity, history of sensitivity to multiple allergens, or previous IgE-mediated reactions (eg, anaphylaxis, angioedema, urticaria). Administration to patients with confirmed penicillin allergies should be avoided; in patients with confirmed cephalosporin allergy, consider skin testing to rule out cross-sensitivity to penicillins.  Epstein-Barr virus infection (infectious mononucleosis), acute lymphocytic leukemia, or cytomegalovirus infection increase risk for ampicillin-induced maculopapular rash. Appearance of a rash should be carefully evaluated to differentiate a nonallergic ampicillin rash from a hypersensitivity reaction; rash occurs in 5% to 10% of children and is a generalized dull red, maculopapular rash, generally appearing 3-14 days after the start of therapy. It normally begins on the trunk and spreads over most of the body. It may be most intense at pressure areas, elbows, and knees. Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298749\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F135063\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Allopurinol: May enhance the potential for allergic or hypersensitivity reactions to Ampicillin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atenolol: Ampicillin may decrease the bioavailability of Atenolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chloroquine: May decrease the serum concentration of Ampicillin. Management: Chloroquine prescribing information recommends separating administration of ampicillin and chloroquine by at least 2 hours to minimize any potential negative impact of chloroquine on ampicillin bioavailability.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fusidic Acid: May diminish the therapeutic effect of Penicillins.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lanthanum: May decrease the serum concentration of Ampicillin. Management: Administer oral ampicillin at least two hours before or after lanthanum.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Penicillins may increase the serum concentration of Methotrexate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Penicillins may decrease serum concentrations of the active metabolite(s) of Mycophenolate. This effect appears to be the result of impaired enterohepatic recirculation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Penicillins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: May diminish the therapeutic effect of Penicillins.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Penicillins may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F135066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F6028245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have not been observed in animal reproduction studies. Both ampicillin and sulbactam cross the placenta. Maternal use of penicillins has generally not resulted in an increased risk of birth defects. When used during pregnancy, pharmacokinetic changes have been observed with ampicillin alone (refer to the Ampicillin monograph for details). Ampicillin/sulbactam may be considered for prophylactic use prior to cesarean delivery (consult current guidelines).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1045192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     With prolonged therapy monitor hematologic, renal, and hepatic function; observe for change in bowel frequency; monitor for signs of anaphylaxis during first dose",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1045183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sulbactam has very little antibacterial activity by itself. The addition of sulbactam, a beta-lactamase inhibitor, to ampicillin extends the spectrum of ampicillin to include beta-lactamase producing organisms; ampicillin acts by inhibiting bacterial cell wall synthesis during the stage of active multiplication",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1045198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ampicillin:  See Ampicillin monograph",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Sulbactam:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Distribution: Into bile, blister and tissue fluids; poor penetration into CSF with uninflamed meninges; higher concentrations attained with inflamed meninges; V",
"     <sub>",
"      d",
"     </sub>",
"     (Nahata, 1999):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 1-12 years: ~0.35 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: 0.25 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Protein binding: 38%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 1-12 years: Mean range: ~0.7-0.9 hours with normal renal function (Nahata, 1999)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: 1-1.3 hours  with normal renal function",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Elimination: Urine (~75% to 85% as unchanged drug) within 8 hours",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1045200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sodium content of 1.5 g (1 g ampicillin plus 0.5 g sulbactam): 5 mEq",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Baddour LM, Wilson WR, Bayer AS, et al, \"Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2005, 111(23):e394-434.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/15956145/pubmed\" id=\"15956145\" target=\"_blank\">",
"        15956145",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dajani AS, &ldquo;Sulbactam/Ampicillin in Pediatric Infections,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1988, 35(Suppl 7):35-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/3065053/pubmed\" id=\"3065053\" target=\"_blank\">",
"        3065053",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dajani A, \"Use of Ampicillin/Sulbactam and Sultamicillin in Pediatric Infections: A Re-evaluation,\"",
"      <i>",
"       J Int Med Res",
"      </i>",
"      , 2001, 29(4):257-69.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/11675898/pubmed\" id=\"11675898\" target=\"_blank\">",
"        11675898",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Goldfarb J, Aronoff SC, Jaff&eacute; A, et al, &ldquo;Sultamicillin in the Treatment of Superficial Skin and Soft Tissue Infections in Children,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1987, 31(4):663-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/3038003/pubmed\" id=\"3038003\" target=\"_blank\">",
"        3038003",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Heintz BH, Matzke GR, Dager WE, &ldquo;Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2009, 29(5):562-77.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/19397464/pubmed\" id=\"19397464\" target=\"_blank\">",
"        19397464",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kulhanjian J, Dunphy MG, Hamstra S, et al, &ldquo;Randomized Comparative Study of Ampicillin/Sulbactam vs Ceftriaxone for Treatment of Soft Tissue and Skeletal Infections in Children,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 1989, 8(9):605-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/2677956/pubmed\" id=\"2677956\" target=\"_blank\">",
"        2677956",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Manzoni P, Esposito S, Gallo E, et al, \"Switch Therapy in Full-Term Neonates With Presumed or Proven Bacterial Infection,\"",
"      <i>",
"       J Chemother",
"      </i>",
"      , 2009, 21(1):68-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/19297276/pubmed\" id=\"19297276\" target=\"_blank\">",
"        19297276",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nahata MC, Vashi VI, Swanson RN, et al, \"Pharmacokinetics of Ampicillin and Sulbactam in Pediatric Patients,\"",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1999, 43(5):1225-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/10223940/pubmed\" id=\"10223940\" target=\"_blank\">",
"        10223940",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Solomkin JS, Mazuski JE, Bradley JS, et al, &ldquo;Diagnosis and Management of Complicated Intra-Abdominal Infections in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      ,  2010, 50(2):133-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/20034345/pubmed\" id=\"20034345\" target=\"_blank\">",
"        20034345",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sutton AM, Turner TL, Cockburn F, et al, \"Pharmacokinetic Study of Sulbactam and Ampicillin Administered Concomitantly by Intraarterial or Intravenous Infusion in the Newborn,\"",
"      <i>",
"       Rev Infect Dis",
"      </i>",
"      , 1986, 8(Suppl 5):518-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/3025999/pubmed\" id=\"3025999\" target=\"_blank\">",
"        3025999",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Syriopoulou V, Bitsi M, Theodoridis C, et al, &ldquo;Clinical Efficacy of Sulbactam/Ampicillin in Pediatric Infections Caused by Ampicillin-Resistant or Penicillin-Resistant Organisms,&rdquo;",
"      <i>",
"       Rev Infect Dis",
"      </i>",
"      , 1986, 8(Suppl 5):S630-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/3026016/pubmed\" id=\"3026016\" target=\"_blank\">",
"        3026016",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Trotman RL, Williamson JC, Shoemaker DM, et al, &ldquo;Antibiotic Dosing in Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41(8):1159-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/16163635/pubmed\" id=\"16163635\" target=\"_blank\">",
"        16163635",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Workowski KA, Berman S, and Centers for Disease Control and Prevention (CDC), \"Sexually Transmitted Diseases Treatment Guidelines, 2010,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2010, 59(RR-12):1-110.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?29/3/29750/abstract-text/21160459/pubmed\" id=\"21160459\" target=\"_blank\">",
"        21160459",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12695 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-F0C764AA00-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29750=[""].join("\n");
var outline_f29_3_29750=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135090\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135091\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045193\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13361887\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045186\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135070\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135054\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045196\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135118\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045190\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045195\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135117\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045199\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045185\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045184\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298749\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135063\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135066\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6028245\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045192\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045183\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045198\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045200\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12695\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12695|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1160?source=related_link\">",
"      Ampicillin and sulbactam: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?35/3/35891?source=related_link\">",
"      Ampicillin and sulbactam: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_3_29751="Overview of psychotherapies";
var content_f29_3_29751=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of psychotherapies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/3/29751/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/3/29751/contributors\">",
"     Jay Lebow, PhD, ABPP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/3/29751/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/3/29751/contributors\">",
"     Thomas L Schwenk, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/3/29751/contributors\">",
"     Andrew Skodol, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/3/29751/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/3/29751/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/3/29751/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?29/3/29751/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H432861989\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychotherapy is an interpersonal treatment based on psychological principles. It is individualized to the patient, seeking to help him or her with a psychiatric disorder, problem, or adverse circumstance [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/1\">",
"     1",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    There are many types of psychotherapy with varying methods and levels of empirical support. The choice of the most appropriate type of psychotherapy is in part based upon the patient&rsquo;s specific problem or diagnosis (",
"    <a class=\"graphic graphic_table graphicRef80990 \" href=\"UTD.htm?8/54/9068\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    This topic will provide an overview of psychotherapy to help the clinician providing psychotherapy, or referring a patient to a mental health provider for psychotherapy, explain the rationale for such therapy to a patient. More detailed discussions of psychotherapy for specific disorders are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/42/28328?source=see_link\">",
"     \"Depression in adults: Psychodynamic psychotherapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/16/17674?source=see_link\">",
"     \"Interpersonal Psychotherapy (IPT) for depressed adults: Indications, theoretical foundation, general concepts, and efficacy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32327?source=see_link\">",
"     \"Psychotherapy for social anxiety disorder\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/22/40297?source=see_link\">",
"     \"Psychotherapy for panic disorder\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5032?source=see_link\">",
"     \"Psychotherapy for posttraumatic stress disorder\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/38/2665?source=see_link\">",
"     \"Pharmacotherapy for generalized anxiety disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H154312384\">",
"    <span class=\"h1\">",
"     EVIDENCE-BASED PSYCHOTHERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are many named psychotherapies, most are derivations of a few basic types. Psychotherapies within each of these categories broadly share a similar explanatory model and set of techniques. However, therapies are frequently modified (and may be renamed) when applied to new conditions or populations. Clinical trials have found each of the following psychotherapies, when administered under structured protocols by trained therapists, to be effective for specific psychiatric disorders (",
"    <a class=\"graphic graphic_table graphicRef80990 \" href=\"UTD.htm?8/54/9068\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cognitive and behavioral psychotherapies",
"     </li>",
"     <li>",
"      Psychodynamic psychotherapy",
"     </li>",
"     <li>",
"      Interpersonal psychotherapy",
"     </li>",
"     <li>",
"      Motivational interviewing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In some cases, psychotherapy may be more effective when administered in conjunction with medication. Efficacy data are described in detail separately under individual disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432862147\">",
"    <span class=\"h2\">",
"     Cognitive and behavioral therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive and behavioral therapies can be used individually or in combination as a program of interventions known as cognitive behavioral therapy or CBT. CBT often includes education, relaxation exercises, coping skills training, stress management, or assertiveness training [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In cognitive therapy, the therapist helps the patient identify and correct distorted, maladaptive beliefs. Behavioral therapy uses thought exercises or real experiences to facilitate symptom reduction and improved functioning. This may occur through learning, through decreased reactivity from repeated exposure to a stimulus, or through other mechanisms.",
"   </p>",
"   <p>",
"    Individuals for whom cognitive behavioral therapy works best are generally highly motivated and value a problem-solving approach, because therapy requires that the patient learns the skills of self-observation. Patients learn cognitive and behavioral skills and practice them within and outside of the therapy setting.",
"   </p>",
"   <p>",
"    Cognitive behavioral therapy is an evidence-based treatment for psychiatric disorders including depression, generalized anxiety disorder, post-traumatic stress disorder, panic disorder, eating disorders, and obsessive compulsive disorder, as well as several medical conditions (eg, insomnia, smoking, low back pain). These applications are discussed in detail separately. We have listed only some of the representative topics given that CBT is utilized in a large number of psychiatric and medical conditions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/28/8646?source=see_link\">",
"     \"Binge-eating disorder: Cognitive-behavioral therapy (CBT)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7560?source=see_link\">",
"     \"Bulimia nervosa in adults: Cognitive-behavioral therapy (CBT)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21385?source=see_link\">",
"     \"Anorexia nervosa in adults: Cognitive-behavioral therapy (CBT)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4244440\">",
"    <span class=\"h2\">",
"     Psychodynamic psychotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychodynamic therapy primarily relies on developing patient insight [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/4\">",
"     4",
"    </a>",
"    ]. Psychodynamic psychotherapy is based upon the idea that childhood experiences, past unresolved conflicts, and previous relationships significantly influence an individual&rsquo;s current situation in life. Adult relationships are understood to be a byproduct of unconscious patterns that begin in childhood. Psychodynamic psychotherapy uncovers the unconscious patterns of interpersonal relationships, conflicts, and desires with the goal of improved functioning [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Psychodynamic therapy is used for some psychiatric disorders, including depression, anorexia nervosa, and personality disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/42/28328?source=see_link\">",
"     \"Depression in adults: Psychodynamic psychotherapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40824?source=see_link\">",
"     \"Personality disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4244571\">",
"    <span class=\"h2\">",
"     Interpersonal psychotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interpersonal therapy (IPT) addresses interpersonal difficulties that lead to psychological problems [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/6\">",
"     6",
"    </a>",
"    ]. Interpersonal psychotherapy focuses on the individual&rsquo;s interpersonal life in four problem areas: grief over loss, interpersonal disputes, role transitions, and interpersonal skill deficits.",
"   </p>",
"   <p>",
"    Interpersonal therapy is an evidence-based treatment for some psychiatric conditions, including depression, bipolar disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/7\">",
"     7",
"    </a>",
"    ], and eating disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/16/17674?source=see_link\">",
"     \"Interpersonal Psychotherapy (IPT) for depressed adults: Indications, theoretical foundation, general concepts, and efficacy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/14/4328?source=see_link&amp;anchor=H14#H14\">",
"     \"Psychosocial treatment for adolescent depression\", section on 'Interpersonal psychotherapy for adolescents (IPT-A)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432862274\">",
"    <span class=\"h2\">",
"     Motivational interviewing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Motivational interviewing is a type of psychotherapy that is used in primary care and mental health care to encourage patients to change maladaptive behaviors [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/8\">",
"     8",
"    </a>",
"    ]. Derived from cognitive-behavioral and readiness-to-change models, motivational interviewing seeks to help patients recognize and make changes to these behaviors, matching strategies to the patient&rsquo;s stage of readiness to change. Key elements of motivational interviewing include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Expressing empathy",
"     </li>",
"     <li>",
"      Helping the patient identify discrepancies between his or her problematic behaviors and broader, personal values",
"     </li>",
"     <li>",
"      Expecting the patient to resist change and accepting it",
"     </li>",
"     <li>",
"      Enhancing the patient&rsquo;s self-efficacy (ie, confidence in his or her capability to surmount obstacles and successfully change)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The intensity of motivational interviewing can vary, but efficacious models are approximately 60 minutes in length, delivered over one to five sessions. The use of motivational interviewing is growing, and has been applied to the treatment of substance abuse disorders, promoting lifestyle changes (eg, weight reduction, smoking cessation), and encouraging adherence to complex medical treatments (eg, heart failure self-management). It is often employed as an evidence-based adjunct to other interventions when encountering low levels of patient motivation to change [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/16/2313?source=see_link\">",
"     \"Motivational interviewing for substance use disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42265?source=see_link&amp;anchor=H1008367#H1008367\">",
"     \"Brief intervention for unhealthy alcohol and other drug use\", section on 'Motivational interviewing'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12904?source=see_link\">",
"     \"Smoking cessation counseling strategies in primary care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42616?source=see_link\">",
"     \"Breastfeeding: Parental education and support\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/55/25465?source=see_link&amp;anchor=H6600037#H6600037\">",
"     \"Heart failure self management\", section on 'Behavior change/patient engagement'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18378?source=see_link&amp;anchor=H5800644#H5800644\">",
"     \"Management of childhood obesity in the primary care setting\", section on 'Motivational interviewing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1154004\">",
"    <span class=\"h1\">",
"     OTHER PSYCHOTHERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other psychotherapies that are widely used vary in approach from one therapist to the next. Their efficacy has not been systematically studied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432862296\">",
"    <span class=\"h2\">",
"     Supportive psychotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supportive psychotherapy or counseling is widely used in medical practice, eg, to help individuals cope with illness, deal with a crisis or transient problem, and maintain optimism or hope [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/9\">",
"     9",
"    </a>",
"    ]. Techniques vary but most models emphasize communication of interest and empathy; supportive therapy may also include guidance on available services, advice, respect, praise,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    encouragement. The efficacy and administration of supportive psychotherapy for depression is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/13/16601?source=see_link\">",
"     \"Depression in adults: Supportive psychotherapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432862194\">",
"    <span class=\"h2\">",
"     Eclectic or integrative psychotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In surveys of mental health clinicians in the US and Canada, a majority of clinicians (psychiatrists, psychologists, social workers, and others) identified themselves as practicing an eclectic or integrative form of psychotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Eclectic and integrative therapists draw concepts and techniques from a variety of different types of therapy, including psychodynamic, cognitive, and behavioral approaches [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H158682494\">",
"    <span class=\"h1\">",
"     FORMAT OF PSYCHOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the orientation of therapy, treatment is offered in different formats. Therapy may be presented to the individual, a couple, a family unit, or in a group of individuals or peers who are not related.",
"   </p>",
"   <p>",
"    There is generally no single preferred format, although there is evidence that some problems respond better or worse to different configurations. As an example, the preponderance of clinical experience and study data indicate that couple therapy is useful for marital problems [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/13\">",
"     13",
"    </a>",
"    ]. Group therapy for adolescents with problem behavior may result in increased delinquency, whereas group therapy may be helpful for adults with substance abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H158682519\">",
"    <span class=\"h2\">",
"     Individual therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individual therapy is the most commonly practiced format of psychotherapy. Individual therapy allows for a confidential interaction between patient and provider, permitting maximal disclosure without fear of others listening or interrupting. The majority of the evidence for practicing psychotherapy involves individual therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H158682526\">",
"    <span class=\"h2\">",
"     Couple therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Couple therapy or marital therapy allows two partners to overcome relationship difficulties with the therapist. Specific issues that may be addressed with couple therapy include sexual relations and parenting [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. It is a valuable adjunctive treatment in some disorders such as depression [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/17\">",
"     17",
"    </a>",
"    ] and substance use disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/18\">",
"     18",
"    </a>",
"    ], particularly when there is comorbid relationship distress [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H158682533\">",
"    <span class=\"h2\">",
"     Family therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Family therapies, in which family members are seen together in treatment, focus on the family system and its ability to help both family problems and individual psychopathology [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Family therapy attempts to correct distorted communications and impaired relationships as a means of helping the entire family, including the patient with the psychiatric disorder. For patients with schizophrenia and bipolar disorder, family psychoeducation helps family members learn about the disorder, solve problems, and cope more constructively with the patient's illness [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/21\">",
"     21",
"    </a>",
"    ]. Using family therapy to treat depressed patients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18025?source=see_link\">",
"     \"Family and couples therapy for treating depressed adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H158682540\">",
"    <span class=\"h2\">",
"     Group therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Group psychotherapy offers supportive networks for people who have similar difficulties [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/22\">",
"     22",
"    </a>",
"    ]. Cognitive, psychodynamic, and supportive techniques may be used. Group therapy is often used for bereavement, in patients with a substance use disorder, or in patients experiencing a chronic or life-threatening condition such as diabetes or cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H432862411\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR PSYCHOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should consider initiating or referring a patient for psychotherapy for the following purposes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment of a psychiatric disorder, with the goal of reducing or ameliorating symptoms and improving functioning",
"     </li>",
"     <li>",
"      Changing maladaptive thoughts, behaviors, or relationships",
"     </li>",
"     <li>",
"      Providing support when a crisis, a difficult period, or a chronic problem impairs functioning",
"     </li>",
"     <li>",
"      Enhancing a patient&rsquo;s capacity to make behavioral changes, eg, losing weight, quitting smoking, or increasing adherence to medical treatment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patient improvement in psychotherapy varies by presenting disorder or problem, its severity and complexity, and the particular treatment provided in each case. The likelihood of improvement is discussed separately for individual disorders. The patient and therapist should set realistic goals for treatment and periodically evaluate whether these goals are being met. If improvement does not occur within the planned duration of treatment, the intervention should be reassessed and other clinical options should be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H71600832\">",
"    <span class=\"h1\">",
"     STAFF AND SETTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychotherapy may be provided by many types of clinicians, including psychiatrists and other physicians, nurses, psychologists, social workers, counselors, and marital and family therapists. However, most types of psychotherapy require specialized training, and one cannot assume the type of therapy a clinician provides from his or her profession. If asked by a patient or referring physician, therapists should provide information about the type of therapy they provide and training they have received. &nbsp;",
"   </p>",
"   <p>",
"    Mental health clinicians (including psychiatrists, psychologists, social workers, counselors,",
"    <span class=\"nowrap\">",
"     marital/family",
"    </span>",
"    therapists, and psychiatric nurses) may work in mental health specialty settings, including individual practices, group practices, and mental health clinics, or they may work in general-medical or multi-specialty medical settings (groups, clinics, hospitals).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H71601971\">",
"    <span class=\"h2\">",
"     Psychotherapy in primary care",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients receiving treatment for a nonpsychotic psychiatric disorder in the US receive treatment in primary care rather than in the mental health specialty sector [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/23\">",
"     23",
"    </a>",
"    ]. Mental health care in primary care has distinctive characteristics compared to mental health specialty care including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients are much more likely to receive pharmacotherapy than psychotherapy in primary care, compared to the mental health specialty setting.",
"     </li>",
"     <li>",
"      Patients are more likely to be treated for depression or an anxiety disorder in primary care, and less likely to be treated for a psychotic disorder.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because patients with psychiatric disorders frequently present in primary care, and mental health specialty care may be unavailable or unacceptable to the patient, numerous interventions have been developed and tested to enhance or expand mental health care in primary care. These models include training of primary care clinicians to provide evidence-based psychotherapy, as well as structural changes to primary care known as integrated care. Although numerous models for providing mental health care in primary care have been studied, they are not widely implemented.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1681009\">",
"    <span class=\"h3\">",
"     Primary care clinicians with psychotherapy training",
"    </span>",
"    &nbsp;&mdash;&nbsp;Randomized trials have found that primary care clinicians and nurses who receive training in an evidence-based psychotherapy can achieve improved outcomes compared to a control intervention, particularly when working with patients with major depression or excessive alcohol use [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/24-30\">",
"     24-30",
"    </a>",
"    ]. Because primary care clinicians are subject to competing demands and time constraints, researchers are working to identify patient subgroups that can be effectively treated with briefer versions of evidence-based psychotherapies (shorter session lengths and fewer sessions). Patients with more severe, complex, or refractory conditions may be better suited for referral to mental health specialty care. Brief psychological treatments in primary care typically involve between two and ten sessions on a weekly basis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/29\">",
"     29",
"    </a>",
"    ]. Most of these therapies are variations of cognitive behavioral therapy used in the treatment of depression and anxiety disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H340973\">",
"    <span class=\"h3\">",
"     Integrated primary and specialty care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Integrated care refers to the availability of mental health specialty care in the context of primary care [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/31\">",
"     31",
"    </a>",
"    ]. In its most basic form, integration may consist of co-location of clinicians. However, observational studies suggest that integrated models may be more effective if communication and coordination occur between primary care and mental health clinicians [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effectiveness of integrated primary care with trained therapists providing an evidence-based psychotherapy is suggested by a large randomized trial involving 932 depressed outpatients at 46 primary care clinics who elected to receive psychotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/33\">",
"     33",
"    </a>",
"    ]. Patients were randomly assigned to usual care or provided access to 12 to 16 sessions of psychotherapy with a local therapist trained in CBT for depression. Treatment was coordinated by the patient&rsquo;s primary care clinic, which provided patient education and monitoring. At 6 and 12 months post-study, patients assigned to psychotherapy were 8 to 10 percentage points less likely to have a depressive disorder compared to patients in usual care.",
"   </p>",
"   <p>",
"    Treatments also have begun to be developed specifically for primary care settings. Problem-solving therapy incorporates cognitive behavioral therapy strategies and is based upon the principle that depression is connected to social problems. One goal of therapy is to develop rational and effective problem solving skills (positive problem orientation). Patients endeavor to identify and define their problems. For each problem, patients are guided to consider the barriers to its resolution, to set an achievable goal, and to evaluate the advantages and disadvantages for all possible solutions (brainstorming). Once the options are evaluated, patients then choose one option, develop an action plan, implement the plan, and evaluate the outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29751/abstract/34\">",
"     34",
"    </a>",
"    ]. In a clinical trial comparing problem solving therapy to usual care and watchful waiting in 141 patients with minor depression, patients treated with problem-solving therapy improved more than those in watchful waiting and faster than in usual care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/16/25858?source=see_link\">",
"       \"Patient information: Anorexia nervosa (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/45/8914?source=see_link\">",
"       \"Patient information: Post-traumatic stress disorder (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=see_link\">",
"       \"Patient information: Depression in adults (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=see_link\">",
"       \"Patient information: Depression treatment options for adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2211306\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Psychotherapy is an interpersonal treatment based on psychological principles. It is individualized to the patient, seeking to help him or her with a psychiatric disorder, problem, or adverse circumstance. There are different types of psychotherapy with varying methods and levels of supporting evidence. Psychotherapies shown to be effective for individual psychiatric disorders include (",
"      <a class=\"graphic graphic_table graphicRef80990 \" href=\"UTD.htm?8/54/9068\">",
"       table 1",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H154312384\">",
"       'Evidence-based psychotherapies'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Cognitive and behavioral psychotherapies",
"     </li>",
"     <li>",
"      Psychodynamic psychotherapy",
"     </li>",
"     <li>",
"      Interpersonal psychotherapy",
"     </li>",
"     <li>",
"      Motivational interviewing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Psychotherapy can be useful intervention for the following indications (see",
"      <a class=\"local\" href=\"#H432862411\">",
"       'Indications for psychotherapy'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Treatment of a psychiatric disorder, with the goal of reducing or ameliorating symptoms and improving functioning",
"     </li>",
"     <li>",
"      Changing maladaptive thoughts, behaviors, or relationships",
"     </li>",
"     <li>",
"      Providing support when a crisis, a difficult period, or a chronic problem impairs functioning",
"     </li>",
"     <li>",
"      Enhancing a patient&rsquo;s capacity to make behavioral changes (eg, losing weight, quitting smoking, or increasing adherence to medical treatment)",
"     </li>",
"     <li>",
"      Increasing family cooperation in enhancing treatment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Psychotherapy is provided by many different types of clinicians, including psychiatrists and other physicians, nurses, psychologists, social workers, counselors, and marital and family therapists. However, many types of psychotherapy require specialized training. If asked by a patient or referring physician, therapists should provide information about the type of therapy they provide and training they have received. (See",
"      <a class=\"local\" href=\"#H71600832\">",
"       'Staff and setting'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of patients receiving treatment for a psychiatric disorder in the US receive this treatment in primary care rather than in the mental health specialty sector. Evidence-based psychotherapy is not generally available in primary care. However, models of mental health care delivery in the primary care setting shown to be effective include (see",
"      <a class=\"local\" href=\"#H71601971\">",
"       'Psychotherapy in primary care'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Primary care clinicians who receive training in an evidence-based psychotherapy",
"     </li>",
"     <li>",
"      Mental health specialists who work collaboratively with clinicians in the primary care setting",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Lebow JL. Twenty-first century psychotherapies: Contemporary approaches to theory and practice, John Wiley &amp; Sons, Hoboken, NJ 2008.",
"    </li>",
"    <li>",
"     Nathan PE, Gorman JM. A guide to treatments that work, 3rd ed, Oxford University Press, New York 2007. p.xxv.",
"    </li>",
"    <li>",
"     Beck JS. Cognitive Behavior Therapy: Basics and Beyond, 2nd ed, Guilford Press, New York 2011. p.391.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/4\">",
"      Shedler J. The efficacy of psychodynamic psychotherapy. Am Psychol 2010; 65:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/5\">",
"      Goldberg PE. The physician-patient relationship: three psychodynamic concepts that can be applied to primary care. Arch Fam Med 2000; 9:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/6\">",
"      van Schaik A, van Marwijk H, Ad&egrave;r H, et al. Interpersonal psychotherapy for elderly patients in primary care. Am J Geriatr Psychiatry 2006; 14:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/7\">",
"      Geller RE, Goldberg JF. A review of evidence-based psychotherapies for bipolar disorder. Primary Psychiatry 2007; 14:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/8\">",
"      Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol 2005; 1:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/9\">",
"      Winston A, Pinsker H, McCullough L. A review of supportive psychotherapy. Hosp Community Psychiatry 1986; 37:1105.",
"     </a>",
"    </li>",
"    <li>",
"     Orlinsky DE, Ronnestad MH. How Psychotherapists Develop: A study of therapeutic work and professional growth, American Psychological Association, Washington, DC 2005. p.xi, 325.",
"    </li>",
"    <li>",
"     Lebow JL. Integrative and eclectic therapies at the beginning of the twenty-first century. In: Comprehensive handbook of psychotherapy: Integrative/Eclectic, Kaslow FW, Lebow JL.  (Eds), John Wiley &amp; Sons, Hoboken, NJ 2004. Vol 4, p.1.",
"    </li>",
"    <li>",
"     Handbook of psychotherapy, 2nd ed, Norcross JC, Goldfried MR.  (Eds), Oxford University Press, London 2005. p.548.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/13\">",
"      Gurman AS, Kniskern DP. Commentary: Individual marital therapy: Have reports of your death been somewhat exaggerated? Fam Process 1986; 25:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/14\">",
"      Dishion TJ, McCord J, Poulin F. When interventions harm. Peer groups and problem behavior. Am Psychol 1999; 54:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/15\">",
"      Lebow JL, Chambers AL, Christensen A, Johnson SM. Research on the treatment of couple distress. J Marital Fam Ther 2012; 38:145.",
"     </a>",
"    </li>",
"    <li>",
"     Gurman AS. Clinical handbook of couple therapy, 4th ed, Guilford Press, New York 2008. p.736.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/17\">",
"      Beach SR, Whisman MA. Affective disorders. J Marital Fam Ther 2012; 38:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/18\">",
"      O'Farrell TJ, Clements K. Review of outcome research on marital and family therapy in treatment for alcoholism. J Marital Fam Ther 2012; 38:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/19\">",
"      Sprenkle DH. Intervention research in couple and family therapy: a methodological and substantive review and an introduction to the special issue. J Marital Fam Ther 2012; 38:3.",
"     </a>",
"    </li>",
"    <li>",
"     Lebow J. Handbook of clinical family therapy, John Wiley &amp; Sons, Hoboken, NJ 2005. p.630.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/21\">",
"      Lucksted A, McFarlane W, Downing D, Dixon L. Recent developments in family psychoeducation as an evidence-based practice. J Marital Fam Ther 2012; 38:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/22\">",
"      Casa&ntilde;as S&aacute;nchez R, Raya Tena A, Ib&aacute;&ntilde;ez P&eacute;rez L, Valls Colomer MM. [Psycho-education group therapy in patients with anxiety and depression in Barcelona Primary Care]. Aten Primaria 2009; 41:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/23\">",
"      Regier DA, Narrow WE, Rae DS, et al. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993; 50:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/24\">",
"      Whitlock EP, Polen MR, Green CA, et al. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004; 140:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/25\">",
"      Alexander CL, Arnkoff DB, Glass CR. Bringing psychotherapy to primary care: Innovations and challenges. Clin Psychol Sci Pract 2010; 17:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/26\">",
"      Clark MS, Smith PO, Payne TJ, Lo V. FPIN's clinical inquiries. Psychosocial interventions delivered by primary care physicians to patients with depression. Am Fam Physician 2006; 74:1580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/27\">",
"      Huibers MJ, Beurskens AJ, Bleijenberg G, van Schayck CP. Psychosocial interventions by general practitioners. Cochrane Database Syst Rev 2007; :CD003494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/28\">",
"      Kaner EF, Dickinson HO, Beyer F, et al. The effectiveness of brief alcohol interventions in primary care settings: a systematic review. Drug Alcohol Rev 2009; 28:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/29\">",
"      Cape J, Whittington C, Buszewicz M, et al. Brief psychological therapies for anxiety and depression in primary care: meta-analysis and meta-regression. BMC Med 2010; 8:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/30\">",
"      Bower P, Rowland N. Effectiveness and cost effectiveness of counselling in primary care. Cochrane Database Syst Rev 2006; :CD001025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/31\">",
"      Oxman TE, Dietrich AJ, Schulberg HC. Evidence-based models of integrated management of depression in primary care. Psychiatr Clin North Am 2005; 28:1061.",
"     </a>",
"    </li>",
"    <li>",
"     Strosahl, K. Integrating behavioral health and primary care. In: Integrated primary care: The future of medical and mental health collaboration, A Blount.  (Ed), W.W. Norton, New York 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/33\">",
"      Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA 2000; 283:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29751/abstract/34\">",
"      Oxman TE, Hegel MT, Hull JG, Dietrich AJ. Problem-solving treatment and coping styles in primary care for minor depression. J Consult Clin Psychol 2008; 76:933.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14612 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-2E861B2D37-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29751=[""].join("\n");
var outline_f29_3_29751=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2211306\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H432861989\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H154312384\">",
"      EVIDENCE-BASED PSYCHOTHERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H432862147\">",
"      Cognitive and behavioral therapies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4244440\">",
"      Psychodynamic psychotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4244571\">",
"      Interpersonal psychotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H432862274\">",
"      Motivational interviewing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1154004\">",
"      OTHER PSYCHOTHERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H432862296\">",
"      Supportive psychotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H432862194\">",
"      Eclectic or integrative psychotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H158682494\">",
"      FORMAT OF PSYCHOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H158682519\">",
"      Individual therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H158682526\">",
"      Couple therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H158682533\">",
"      Family therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H158682540\">",
"      Group therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H432862411\">",
"      INDICATIONS FOR PSYCHOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H71600832\">",
"      STAFF AND SETTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H71601971\">",
"      Psychotherapy in primary care",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1681009\">",
"      - Primary care clinicians with psychotherapy training",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H340973\">",
"      - Integrated primary and specialty care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2211306\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/14612\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/14612|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/54/9068\" title=\"table 1\">",
"      Psychotherapies of choice",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21385?source=related_link\">",
"      Anorexia nervosa in adults: Cognitive-behavioral therapy (CBT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/28/8646?source=related_link\">",
"      Binge-eating disorder: Cognitive-behavioral therapy (CBT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42616?source=related_link\">",
"      Breastfeeding: Parental education and support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42265?source=related_link\">",
"      Brief intervention for unhealthy alcohol and other drug use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7560?source=related_link\">",
"      Bulimia nervosa in adults: Cognitive-behavioral therapy (CBT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/42/28328?source=related_link\">",
"      Depression in adults: Psychodynamic psychotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/13/16601?source=related_link\">",
"      Depression in adults: Supportive psychotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18025?source=related_link\">",
"      Family and couples therapy for treating depressed adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/55/25465?source=related_link\">",
"      Heart failure self management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/16/17674?source=related_link\">",
"      Interpersonal Psychotherapy (IPT) for depressed adults: Indications, theoretical foundation, general concepts, and efficacy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18378?source=related_link\">",
"      Management of childhood obesity in the primary care setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/16/2313?source=related_link\">",
"      Motivational interviewing for substance use disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/16/25858?source=related_link\">",
"      Patient information: Anorexia nervosa (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=related_link\">",
"      Patient information: Depression in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=related_link\">",
"      Patient information: Depression treatment options for adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/45/8914?source=related_link\">",
"      Patient information: Post-traumatic stress disorder (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40824?source=related_link\">",
"      Personality disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/38/2665?source=related_link\">",
"      Pharmacotherapy for generalized anxiety disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/14/4328?source=related_link\">",
"      Psychosocial treatment for adolescent depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/22/40297?source=related_link\">",
"      Psychotherapy for panic disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5032?source=related_link\">",
"      Psychotherapy for posttraumatic stress disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32327?source=related_link\">",
"      Psychotherapy for social anxiety disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12904?source=related_link\">",
"      Smoking cessation counseling strategies in primary care",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_3_29752="Differentiating constrictive pericarditis and restrictive cardiomyopathy";
var content_f29_3_29752=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Differentiating constrictive pericarditis and restrictive cardiomyopathy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/3/29752/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/3/29752/contributors\">",
"     Paul Sorajja, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/3/29752/contributors\">",
"     Brian D Hoit, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/3/29752/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/3/29752/contributors\">",
"     Martin M LeWinter, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/3/29752/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/3/29752/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?29/3/29752/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 5, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constrictive pericarditis is the result of scarring and consequent loss of the normal elasticity of the pericardial sac. This leads to impairment of ventricular filling in mid and late diastole. As a result, the majority of ventricular filling occurs rapidly in early diastole and the ventricular volume does not increase after the end of the early filling period.",
"   </p>",
"   <p>",
"    Restrictive cardiomyopathy is characterized by a nondilated rigid ventricle, resulting in severe diastolic dysfunction and restrictive filling that produces hemodynamic changes similar to those in constrictive pericarditis.",
"   </p>",
"   <p>",
"    Constrictive pericarditis and restrictive cardiomyopathy both lead to diastolic dysfunction and abnormal ventricular filling. However, because of their markedly different treatments, differentiating between the two conditions is critical. In some patients, the correct diagnosis may be readily suggested from the history or routine diagnostic testing. In others, however, this differentiation cannot be diagnosed before biopsy or even surgical exploration.",
"   </p>",
"   <p>",
"    The distinction between constrictive pericarditis and restrictive cardiomyopathy will be reviewed here. The basic aspects of constrictive pericarditis and idiopathic restrictive cardiomyopathy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link\">",
"     \"Constrictive pericarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23207?source=see_link\">",
"     \"Idiopathic restrictive cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30200245\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY OF RESPIRATORY EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;An understanding of ventricular volume constraints and ventricular interaction is key in any discussion of the hemodynamic differences between constrictive pericarditis and restrictive cardiomyopathy.",
"   </p>",
"   <p>",
"    In patients with constrictive pericarditis, total cardiac volume is fixed by the noncompliant pericardium. The septum is not involved and can therefore bulge toward the left ventricle when left ventricular volume is less than that on the right. As a result, ventricular interdependence is greatly enhanced. This bulging may be seen on echocardiography, or in some cases, on cardiac magnetic resonance imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, changes in intrathoracic pressure are not transmitted to the cardiac chambers because of obliteration of the pericardial space. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link\">",
"     \"Constrictive pericarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In restrictive cardiomyopathy, on the other hand, pericardial compliance is normal. Left ventricular systolic function is normal, or in severe cases, may even be reduced. The respiratory variation in intrathoracic pressure is transmitted normally to the cardiac chambers.",
"   </p>",
"   <p>",
"    The different effects of respiration on ventricular filling between the two diseases may be explained by the following mechanisms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with constrictive pericarditis, the pulmonary capillary wedge pressure is influenced by the inspiratory fall in intra-thoracic pressure, while the left ventricular pressure is shielded from respiratory pressure variations by the pericardial scar. Thus, inspiration lowers the pulmonary capillary wedge pressure, and presumably left atrial pressure, but not left ventricular diastolic pressure, thereby decreasing the pressure gradient for ventricular filling. The less favorable filling pressure gradient during inspiration explains the decline in filling velocity. Reciprocal changes occur in the velocity of right ventricular filling [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/2,3\">",
"       2,3",
"      </a>",
"      ]. These changes are mediated by the ventricular septum, not by increased systemic venous return.",
"     </li>",
"     <li>",
"      In patients with restrictive cardiomyopathy, inspiration lowers pulmonary wedge and left ventricular diastolic pressures equally, thereby leaving the pressure gradient for ventricular filling and filling velocity virtually unchanged.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A lower left ventricular filling pressure gradient with constrictive pericarditis also leads to a delay in mitral valve opening and therefore, a longer isovolumic relaxation time during inspiration. Prolonged isovolumic relaxation of the left ventricle is a feature of both conditions. This finding varies with respiration in constrictive pericarditis, but not restrictive cardiomyopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORY AND PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the evaluation of a patient with suspected constrictive pericarditis or restrictive cardiomyopathy, the history can provide important clues to other systemic disorders which could predispose to either condition. In addition, while most patients with constrictive pericarditis and restrictive cardiomyopathy present with symptoms of heart failure, subtle differences in physical findings may suggest a particular diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the evaluation of constrictive pericarditis versus restrictive cardiomyopathy, the history is most valuable in identifying a systemic disorder which can predispose to either constrictive pericarditis or restrictive cardiomyopathy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prior history of pericarditis, trauma, cardiac surgery, or a systemic disease that affects the pericardium (eg, tuberculosis, connective tissue disease, malignancy) makes the diagnosis of constrictive pericarditis more likely. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/43/30392?source=see_link\">",
"       \"Etiology of pericardial disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link&amp;anchor=H9#H9\">",
"       \"Constrictive pericarditis\", section on 'History'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A history of an infiltrative disease that may involve the heart muscle (eg, amyloidosis, sarcoidosis) favors the diagnosis of restrictive cardiomyopathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/10/23722?source=see_link\">",
"       \"Clinical manifestations and diagnosis of amyloid cardiomyopathy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17722?source=see_link\">",
"       \"Cardiac sarcoidosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23207?source=see_link&amp;anchor=H4#H4\">",
"       \"Idiopathic restrictive cardiomyopathy\", section on 'Clinical Presentation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, prior thoracic radiation treatment can result in either constrictive pericarditis, restrictive cardiomyopathy, or a condition with features of both constrictive pericarditis and restrictive cardiomyopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/21/34137?source=see_link\">",
"     \"Cardiotoxicity of radiation therapy for malignancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link\">",
"     \"Constrictive pericarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vast majority of patients with both constrictive pericarditis and restrictive cardiomyopathy display elevated jugular venous pressure (JVP) on physical examination (",
"    <a class=\"graphic graphic_figure graphicRef80995 \" href=\"UTD.htm?40/1/40976\">",
"     figure 1",
"    </a>",
"    ). From the JVP waveform alone, it is not possible to distinguish between constrictive pericarditis, restrictive cardiomyopathy, tricuspid regurgitation with an enlarged compliant right atrium, or right heart failure (eg, due to right ventricular infarction or pulmonary hypertension). The contour of the jugular venous pulse in all these conditions is dominated by a deep, steep Y descent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/59/33719?source=see_link\">",
"     \"Examination of the jugular venous pulse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional physical examination findings in patients with constrictive pericarditis or restrictive cardiomyopathy can include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Kussmaul's sign (the lack of an inspiratory decline in JVP)",
"     </li>",
"     <li>",
"      Pulsus paradoxus",
"     </li>",
"     <li>",
"      Peripheral edema",
"     </li>",
"     <li>",
"      Ascites and hepatomegaly",
"     </li>",
"     <li>",
"      Pleural effusions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Approximately 50 percent of patients with constrictive pericarditis may present with a pericardial knock (an accentuated heart sound occurring slightly earlier than a third heart sound, which may be audible and rarely is palpable), which is not expected in restrictive cardiomyopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/4\">",
"     4",
"    </a>",
"    ]. Conversely, an audible S3 is frequently present in persons with restrictive cardiomyopathy because of the abrupt cessation of the rapid ventricular filling; this is not usually present in constrictive pericarditis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link&amp;anchor=H10#H10\">",
"     \"Constrictive pericarditis\", section on 'Physical examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23207?source=see_link&amp;anchor=H4#H4\">",
"     \"Idiopathic restrictive cardiomyopathy\", section on 'Clinical Presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     NON-INVASIVE TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients suspected of having either constrictive pericarditis or restrictive cardiomyopathy, based on history and physical examination, should undergo initial evaluation with electrocardiography, chest radiography, and echocardiography. While a particular diagnosis is often made following echocardiography, patients commonly undergo cardiac catheterization, during which invasive hemodynamic evaluation can help elucidate the correct diagnosis. In most patients, particularly those with prior radiation exposure, there is a role for computed tomography (CT) or cardiac magnetic resonance (CMR) imaging. Both CT and CMR provide additional detailed anatomic information about adjacent vascular structures and an accurate measurement of pericardial thickness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;The electrocardiogram may be helpful in distinguishing constrictive pericarditis from restrictive cardiomyopathy. Depolarization abnormalities (such as bundle branch block), ventricular hypertrophy, pathologic Q waves, or impaired atrioventricular conduction strongly favor restrictive cardiomyopathy. Low voltage and isolated repolarization abnormalities can occur in both conditions, although the latter are more common in constrictive pericarditis. Atrial fibrillation is common in the late stages of both diseases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link&amp;anchor=H11#H11\">",
"     \"Constrictive pericarditis\", section on 'Electrocardiography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23207?source=see_link&amp;anchor=H5#H5\">",
"     \"Idiopathic restrictive cardiomyopathy\", section on 'Electrocardiogram'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H740032\">",
"    <span class=\"h2\">",
"     Plasma BNP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma concentrations of B type natriuretic peptide (BNP) are increased in numerous conditions, most notably in patients with left ventricular dysfunction. As a result, plasma BNP has been used in the diagnosis of dyspnea and to assess the efficacy of therapy and estimate prognosis in patients with heart failure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19818?source=see_link\">",
"     \"Natriuretic peptide measurement in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    BNP is released in response to left ventricular dysfunction and wall stretch. Wall stretch is increased in restrictive cardiomyopathy. However, in constrictive pericarditis, the myocardium is normal, and stretch is limited by the thickened pericardium. These physiologic differences suggest that measurement of plasma BNP might have value in distinguishing between these two disorders.",
"   </p>",
"   <p>",
"    The usefulness of BNP in differentiating constrictive pericarditis from restrictive cardiomyopathy has been evaluated in several small studies (each with between 11 and 33 patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Mean BNP levels in patients with restrictive cardiomyopathy have generally been significantly higher than BNP levels seen in patients with constrictive pericarditis. In addition, many patients with constrictive pericarditis had BNP levels at or below 100",
"    <span class=\"nowrap\">",
"     pg/mL,",
"    </span>",
"    a level generally considered the threshold for a normal BNP value. However, one study reported considerable overlap of the measured BNP levels between patients with constrictive pericarditis and restrictive cardiomyopathy when the BNP value was less than 400",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While the data are intriguing, these observations need to be confirmed in a larger number of patients to more thoroughly determine the accuracy of BNP testing for differentiating constrictive pericarditis from restrictive cardiomyopathy. However, because the physiologic rationale is strong, we recommend measurement of plasma BNP early in the evaluation of patients with suspected constrictive pericarditis as a normal value (BNP &lt;100",
"    <span class=\"nowrap\">",
"     pg/mL)",
"    </span>",
"    essentially excludes restrictive cardiomyopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Chest x-ray",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcification of the pericardium (except for scattered calcified plaques which are more consistent with prior asbestos exposure) strongly suggests constrictive pericarditis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef64005 \" href=\"UTD.htm?12/18/12578\">",
"     image 1",
"    </a>",
"    ). However, the absence of calcification is equally compatible with either diagnosis. In one retrospective review of 135 patients with constrictive pericarditis confirmed surgically or at autopsy, only 27 percent had pericardial calcification [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/8\">",
"     8",
"    </a>",
"    ]. The cause of constrictive pericarditis was more likely to be indeterminant when calcification was seen (67 versus 21 percent in the absence of calcification). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link&amp;anchor=H12#H12\">",
"     \"Constrictive pericarditis\", section on 'Chest radiograph'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mild cardiomegaly on chest x-ray is common in both conditions, but more prominent in restrictive cardiomyopathy. This is generally due to atrial rather than ventricular enlargement. Pulmonary venous congestion with or without pleural effusions can be seen in restrictive cardiomyopathy but would not be expected in constrictive pericarditis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23207?source=see_link&amp;anchor=H6#H6\">",
"     \"Idiopathic restrictive cardiomyopathy\", section on 'Chest radiograph'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Pericardial imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no association between increased pericardial thickness and restrictive cardiomyopathy. However, constrictive pericarditis is usually associated with increased thickness of the pericardium (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73214 \" href=\"UTD.htm?11/40/11911\">",
"     image 2",
"    </a>",
"    ). A pericardial thickness exceeding 4 mm is highly suggestive of constrictive pericarditis. However, constrictive pericarditis can also occur in the setting of a non-thickened pericardium. Thus, a normal appearing parietal pericardium does not rule out constrictive pericarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Pericardial thickness can be evaluated using a variety of imaging techniques, including echocardiography, computed tomography (CT), and cardiac magnetic resonance (CMR) imaging. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link&amp;anchor=H274012956#H274012956\">",
"     \"Constrictive pericarditis\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While transthoracic echocardiography is the most frequently imaging modality used in the assessment of suspected pericardial disease, it is also one of the least sensitive for detecting pericardial thickening. In a review of 143 patients with surgically confirmed constrictive pericarditis, a pathologically thickened pericardium (&gt;4 mm) was seen in 82 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/9\">",
"     9",
"    </a>",
"    ]. Approximately 40 percent of patients with constrictive pericarditis had pericardial thickening seen on transthoracic echocardiography.",
"   </p>",
"   <p>",
"    In comparison to transthoracic echocardiography, CT and CMR imaging are more sensitive for the detection of increased pericardial thickness. [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/9,10\">",
"     9,10",
"    </a>",
"    ] In a review of 143 patients with surgically confirmed constrictive pericarditis, pericardial thickening was seen by CT imaging in 86 percent of patients (compared to 43 percent with pericardial thickening seen by transthoracic echocardiography) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/9\">",
"     9",
"    </a>",
"    ]. CMR is similar to CT in its ability to detect pericardial thickening. CMR has a reported accuracy of 93 percent for the ability to detect pericardial thickening of greater than 4 mm [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Doppler echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to its role in evaluating pericardial thickness, transthoracic echocardiography allows for Doppler assessment of hemodynamics, thereby providing significant information that can aid in diagnosing (and differentiating) constrictive pericarditis and restrictive cardiomyopathy. Restrictive cardiomyopathy and constrictive pericarditis share many important hemodynamic characteristics and therefore, have a number of Doppler characteristics in common, most notably a restrictive mitral inflow or ventricular filling pattern (measured as mitral E velocity), with striking E dominance and a short deceleration time (",
"    <a class=\"graphic graphic_waveform graphicRef59321 graphicRef72146 \" href=\"UTD.htm?17/39/18041\">",
"     waveform 1A-B",
"    </a>",
"    ). These findings indicate early rapid filling and are seen in both entities.",
"   </p>",
"   <p>",
"    However, Doppler echocardiography can also provide clues to differentiating constrictive pericarditis and restrictive cardiomyopathy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Respirophasic changes in intrathoracic pressure and ventricular filling &mdash; The respiratory variation in ventricular filling velocity in restrictive cardiomyopathy is usually minimal (less than 10 percent), while patients with constrictive pericarditis may have respiratory variations as high as 30 to 40 percent in ventricular filling velocity (similar to that seen in cardiac tamponade) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51257 \" href=\"UTD.htm?20/13/20692\">",
"       image 3",
"      </a>",
"      ). An echocardiographic study of 30 patients (19 with constrictive pericarditis and 11 with restrictive cardiomyopathy) found that significant respiratory variation in the ventricular inflow peak velocity &ge;10 percent predicted constrictive pericarditis with a sensitivity and specificity of 84 and 91 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/11\">",
"       11",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      However, the ventricular filling velocity is highly influenced by the level of the left atrial pressure. When left atrial pressure is greatly elevated in a patient with constrictive pericarditis, respiratory variation in ventricular filling may not be observed, whereas patients with lower left atrial pressure (ie, due to volume depletion or earlier stage of disease) may have more noticeable changes in ventricular filling velocities with respiration. Left atrial pressure can be reduced on physical examination by asking a patient to move from the supine to seated position; such a maneuver may elicit the abnormality [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/12\">",
"       12",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The ability to assess respirophasic changes in ventricular filling velocities is challenging in patients with atrial fibrillation, due to the presence of variable cardiac cycle length from beat to beat. While some investigators have suggested that respiratory variation can be accurately assessed in patients with atrial fibrillation, we find this to be quite challenging in the average patient [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/13\">",
"       13",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Respiratory variation in mitral E velocity, as with pulsus paradoxus on physical examination, is not specific to constrictive pericarditis and is frequently seen in patients with chronic obstructive pulmonary disease (COPD). In an attempt to distinguish between constrictive pericarditis and COPD, the pulsed-wave Doppler recordings of mitral and superior vena cava flow velocities were compared in 20 patients with COPD who had a 25 percent respiratory variation in mitral E-wave velocity and 20 patients with surgically proven constrictive pericarditis [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/14\">",
"       14",
"      </a>",
"      ]. The patients with pulmonary disease had a marked increase in inspiratory superior vena cava systolic flow velocity which was not seen in those with constrictive pericarditis&nbsp;(",
"      <a class=\"graphic graphic_waveform graphicRef53288 \" href=\"UTD.htm?33/50/34597\">",
"       waveform 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Hepatic venous flow &mdash; Measurement of hepatic venous flow can help to distinguish constrictive pericarditis from restrictive cardiomyopathy. In patients with constrictive pericarditis, there is a reversal of forward flow during expiration, since the right ventricle becomes less compliant as the left ventricle fills more. In contrast, reversal of hepatic vein flow occurs during inspiration in restrictive cardiomyopathy.",
"     </li>",
"     <li>",
"      Color M mode transit time &mdash; Color M mode Doppler shows an excessively rapid transit of blood flow from the mitral orifice to the apex in constrictive pericarditis, whereas the transit is much slower than normal in restrictive cardiomyopathy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Tissue Doppler imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue Doppler imaging provides additional information on myocardial function which can help to distinguish constrictive pericarditis from restrictive cardiomyopathy. In addition, information derived from tissue Doppler imaging can be used in conjunction with information derived from traditional Doppler imaging to aid in making a diagnosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Doppler tissue velocity &mdash; The early diastolic Doppler tissue velocity at the mitral annulus (E') is decreased (&lt;8",
"      <span class=\"nowrap\">",
"       cm/sec)",
"      </span>",
"      in restrictive cardiomyopathy, due to an intrinsic decrease in myocardial contraction and relaxation. In contrast, the transmitral E' is frequently increased (&gt;12",
"      <span class=\"nowrap\">",
"       cm/sec)",
"      </span>",
"      in constrictive pericarditis, since the longitudinal movement of the myocardium is enhanced because of constricted radial motion (",
"      <a class=\"graphic graphic_waveform graphicRef58771 \" href=\"UTD.htm?22/35/23093\">",
"       waveform 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/11,12\">",
"       11,12",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      While E&rsquo; values &lt;8",
"      <span class=\"nowrap\">",
"       cm/sec",
"      </span>",
"      or &gt;12",
"      <span class=\"nowrap\">",
"       cm/sec",
"      </span>",
"      are highly specific for constrictive pericarditis or restrictive cardiomyopathy, many patients will have an E&rsquo; velocity between 8",
"      <span class=\"nowrap\">",
"       cm/sec",
"      </span>",
"      and 12",
"      <span class=\"nowrap\">",
"       cm/sec,",
"      </span>",
"      which is nondiagnostic. Despite excellent specificity of E' for differentiating restrictive cardiomyopathy from constrictive pericarditis, its sensitivity is more modest.",
"     </li>",
"     <li>",
"      Myocardial velocity gradient &mdash; Pulsed-wave tissue Doppler imaging may help to distinguish between constrictive pericarditis and restrictive cardiomyopathy by measuring the myocardial velocity gradient, which is an index of myocardial contraction and relaxation that quantifies the spatial distribution of intramural velocities across the myocardium (",
"      <a class=\"graphic graphic_waveform graphicRef58771 \" href=\"UTD.htm?22/35/23093\">",
"       waveform 3",
"      </a>",
"      ). One study evaluated this use for pulsed-wave tissue Doppler imaging in 15 patients with restrictive cardiomyopathy, 10 patients with constrictive pericarditis, and 30 age-matched normal controls [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/15\">",
"       15",
"      </a>",
"      ]. The Doppler myocardial velocity gradient, as measured from the left ventricular posterior wall in early diastole and during ventricular ejection, was significantly lower in patients with a restrictive cardiomyopathy compared to those with constrictive pericarditis and to normal controls.",
"     </li>",
"     <li>",
"      Other tissue Doppler parameters &mdash; In a study of 17 patients with constrictive pericarditis, 12 patients with restrictive cardiomyopathy, and 15 controls, measurement of systolic mitral annular velocity (S') and the time difference between the onset of transmitral flow and the onset of E' (T(E'-E)) was shown to increase sensitivity and provide incremental diagnostic discriminating information to E' [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CARDIAC CATHETERIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some cases, particularly when there are multiple potential etiologies for heart failure, invasive cardiac catheterization is required to determine the diagnosis. Elevation and equalization of diastolic filling pressures occurs in patients with constrictive pericarditis. Although these hemodynamic findings may occur in patients with other cardiac disorders, their presence is required for the diagnosis of constrictive pericarditis. Diastolic equalization may not be present in patients with constrictive pericarditis in the event of preceding diuresis and a low volume state, as well as in patients with relatively early stage disease. In patients with a low volume state, however, the cardiac output will be low. Therefore, the presence of normal cardiac output with normal filling pressures precludes the presence of hemodynamically significant constrictive pericarditis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      End-diastolic pressures &mdash; Right and left ventricular end-diastolic pressures (RVEDP and LVEDP) are equal or nearly equal in constrictive pericarditis, while LVEDP is usually higher than RVEDP in restrictive cardiomyopathy. However, in many cases of restrictive cardiomyopathy the plateau of diastolic pressure is equally elevated in both ventricles, as typically occurs in constrictive pericarditis. If the pressures are approximately equal, a fluid bolus, exercise, or pharmacologic maneuver should theoretically increase LVEDP above RVEDP in restrictive cardiomyopathy, but the data supporting this theory are not convincing [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/17-19\">",
"       17-19",
"      </a>",
"      ]. The sensitivity and specificity of such maneuvers are not known; therefore, the diagnostic benefit of these maneuvers is uncertain.",
"      <br/>",
"      <br/>",
"      The predictive accuracy of conventional catheterization criteria was 75 percent in 100 consecutive patients undergoing cardiac catheterization to differentiate constrictive pericarditis (n = 59) from restrictive cardiomyopathy (n = 41). Use of a novel \"systolic area index\" ratio (right ventricular to left ventricular systolic pressure-time area during inspiration versus expiration) that estimated enhanced ventricular interdependence had a sensitivity of 97 percent and a predictive accuracy of 100 percent for the identification of patients with surgically documented constrictive pericarditis [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dip and plateau sign &mdash; The first observations of the dip and plateau configuration (",
"      <a class=\"graphic graphic_waveform graphicRef69264 \" href=\"UTD.htm?26/10/26786\">",
"       waveform 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef81335 \" href=\"UTD.htm?6/59/7097\">",
"       figure 2",
"      </a>",
"      ) of ventricular pressure (also called the square root sign) during diastole led investigators to theorize that ventricular filling during early diastole must be unusually rapid and aided by augmented suction, and that ventricular filling must be halted by pericardial restraint from the end of the first third of diastole onward [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/21\">",
"       21",
"      </a>",
"      ]. This conjecture was verified after it became possible to record the pattern of ventricular filling by ventriculography and subsequently by other imaging techniques. Although some disagree, most authors believe (as we do) that the same dip and plateau waveform characterizes restrictive cardiomyopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/22,23\">",
"       22,23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Equalization of pressures &mdash; Equalization of filling pressures in the four cardiac chambers is commonly said to be a major hemodynamic criterion for the diagnosis of constrictive pericarditis. This statement may be an oversimplification for two reasons:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The pulmonary wedge pressure falls during inspiration while systemic venous pressure remains constant. Thus, it is not reasonable to expect the two pressures to be precisely equal throughout the respiratory cycle, and frequently equilibration is present only during inspiration.",
"     </li>",
"     <li>",
"      Equilibration of diastolic pressures occurs in some patients who have heart failure or an acute volume overload, but who do not have constrictive pericarditis.",
"      <br/>",
"      <br/>",
"      In addition, pericardial restraint from a dilated heart may cause equilibration of diastolic pressures and may simulate the hemodynamics of constrictive pericarditis. Examples of this phenomenon are found in right ventricular dilation after right ventricular infarction or severe tricuspid insufficiency, as well as in acute mitral regurgitation secondary to rupture of a chorda tendineae.",
"      <br/>",
"      <br/>",
"      Pulmonary hypertension and left ventricular diastolic pressure that exceeds that in the right ventricle by &ge;5 mmHg may favor a diagnosis of cardiomyopathy (restrictive or dilated) rather than constrictive pericarditis. However, neither of these findings is highly specific for either diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/24\">",
"       24",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Hemodynamic maneuvers, such as exercise, fluid loading, and observing postextrasystolic beats, have been proposed as a way to cause diastolic pressures (equal in the two ventricles) to differ. Published experience with these approaches are limited. In addition, there may not be equalization of diastolic pressures if a patient with constrictive pericarditis has been on diuretics and has low to normal right atrial pressures. In such patients, fluid loading at the time of catheterization is necessary to attempt to confirm the diagnosis of constrictive pericarditis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Respiratory changes &mdash; As noted above, both constrictive pericarditis and restrictive cardiomyopathy may have similar findings of early rapid diastolic filling and elevation and equalization of diastolic pressures in all four cardiac chambers. However, the respiratory changes in filling of the left ventricle and right ventricle, as well as the enhanced ventricular interaction seen in constrictive pericarditis, result in distinctive changes in the left ventricular and right ventricular pressures during respiration. (See",
"      <a class=\"local\" href=\"#H30200245\">",
"       'Pathophysiology of respiratory effects'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      These abnormalities have been described as discordance between the pressures in these two chambers, typically seen as reciprocal changes in stroke volume, pulse pressure, or peak systolic pressure during respiration (",
"      <a class=\"graphic graphic_figure graphicRef73914 \" href=\"UTD.htm?43/48/44801\">",
"       figure 3",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      During inspiration, there is less filling of the left ventricle, resulting in a large fall in left ventricular systolic pressure. The reduction in left ventricular filling is due to the fall in the pulmonary wedge pressure and presumably left atrial pressure resulting from the decrease in intrathoracic pressure. In contrast, left ventricular diastolic pressure does not fall since the left ventricular pressure is shielded from respiratory pressure variations by the pericardial scar. The net effect is a reduction in the pressure gradient for ventricular filling.",
"     </li>",
"     <li>",
"      Due to enhanced ventricular interaction, since the septum can move normally, there is greater filling of the right ventricle and the right ventricular systolic pressure will rise.",
"      <br/>",
"      <br/>",
"      These findings are not present in patients with restrictive cardiomyopathy in whom the left ventricular and right ventricular pressures are concordant during the respiratory cycle. Inspiration lowers pulmonary wedge and left ventricular diastolic pressures equally, thereby leaving the pressure gradient for ventricular filling and filling velocity virtually unchanged. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=see_link&amp;anchor=H17#H17\">",
"       \"Constrictive pericarditis\", section on 'Differential diagnosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Biopsy &mdash; Endomyocardial, or less commonly, pericardial biopsy may be helpful when hemodynamic and imaging studies fail to establish the diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29752/abstract/25,26\">",
"       25,26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18190864\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with both constrictive pericarditis and restrictive cardiomyopathy have elevated left and right sided filling pressures, often of equal magnitude, and usually have normal systolic ventricular function. Findings that can aid in distinguishing the two conditions include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History &mdash; The history may provide helpful clues, such as prior pericarditis or a systemic disease predisposing to constrictive pericarditis, or a cause of restrictive cardiomyopathy (eg, diabetes mellitus or amyloidosis). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Physical Examination &mdash; The vast majority of patients with both constrictive pericarditis and restrictive cardiomyopathy display elevated jugular venous pressure (JVP), making this physical finding less helpful in distinguishing the two conditions. The presence of a pericardial knock (an accentuated heart sound occurring slightly earlier than a third heart sound) favors constrictive pericarditis, while an audible S3 is frequently present in persons with restrictive cardiomyopathy. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Electrocardiography &mdash; The electrocardiogram may be helpful in distinguishing constrictive pericarditis from restrictive cardiomyopathy. Depolarization abnormalities (such as bundle branch block), ventricular hypertrophy, pathologic Q waves, or impaired atrioventricular conduction strongly favor restrictive cardiomyopathy. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Electrocardiogram'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      B-type natriuretic peptide (BNP) &mdash; BNP is released in response to left ventricular dysfunction and wall stretch. Wall stretch is increased in restrictive cardiomyopathy, whereas in constrictive pericarditis the myocardium is usually normal and myocardial wall stretch is limited by the thickened pericardium. Several small observational studies have suggested that BNP levels in patients with restrictive cardiomyopathy are significantly higher than BNP levels in patients with constrictive pericarditis. Because the physiologic rationale is strong and consistent with these preliminary findings, we recommend measurement of plasma BNP early in the evaluation of patients with suspected constrictive pericarditis as a normal value (BNP &lt;100",
"      <span class=\"nowrap\">",
"       pg/mL)",
"      </span>",
"      essentially excludes restrictive cardiomyopathy. (See",
"      <a class=\"local\" href=\"#H740032\">",
"       'Plasma BNP'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chest radiography &mdash; Calcification of the pericardium (except for scattered calcified plaques which are more consistent with prior asbestos exposure) strongly suggests constrictive pericarditis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef64005 \" href=\"UTD.htm?12/18/12578\">",
"       image 1",
"      </a>",
"      ), whereas cardiomegaly on chest x-ray (generally due to atrial rather than ventricular enlargement) is more prominent in restrictive cardiomyopathy. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Chest x-ray'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pericardial imaging &mdash; Increased thickness or calcification of the pericardium favors the diagnosis of constrictive pericarditis, although increased pericardial thickness is not present in all patients. Thickening of the ventricular wall and septum, abnormal myocardial texture, and to a lesser extent, mitral or tricuspid regurgitation favor the diagnosis of restrictive cardiomyopathy. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Pericardial imaging'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Doppler echocardiography &mdash; Doppler echocardiography can provide clues to differentiating constrictive pericarditis and restrictive cardiomyopathy. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Doppler echocardiography'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The respiratory variation in ventricular filling velocity in restrictive cardiomyopathy is usually minimal (less than 10 percent), while patients with constrictive pericarditis may have respiratory variations as high as 30 to 40 percent in ventricular filling velocity.",
"     </li>",
"     <li>",
"      Hepatic venous flow reversal is expiratory in constrictive pericarditis, but inspiratory in restrictive cardiomyopathy. Diastolic mitral regurgitation suggests restrictive cardiomyopathy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tissue Doppler imaging &mdash; Tissue Doppler imaging provides additional information on myocardial function which can help to distinguish constrictive pericarditis from restrictive cardiomyopathy. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Tissue Doppler imaging'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The early diastolic Doppler tissue velocity at the mitral annulus (E') is decreased (&lt;8",
"      <span class=\"nowrap\">",
"       cm/sec)",
"      </span>",
"      in restrictive cardiomyopathy, due to an intrinsic decrease in myocardial contraction and relaxation. In contrast, the transmitral E' is frequently increased (&gt;12",
"      <span class=\"nowrap\">",
"       cm/sec)",
"      </span>",
"      in constrictive pericarditis, since the longitudinal movement of the myocardium is enhanced because of constricted radial motion (",
"      <a class=\"graphic graphic_waveform graphicRef58771 \" href=\"UTD.htm?22/35/23093\">",
"       waveform 3",
"      </a>",
"      ). While E&rsquo; values &lt;8",
"      <span class=\"nowrap\">",
"       cm/sec",
"      </span>",
"      or &gt;12",
"      <span class=\"nowrap\">",
"       cm/sec",
"      </span>",
"      are highly specific for constrictive pericarditis or restrictive cardiomyopathy, many patients will have an E&rsquo; velocity between 8",
"      <span class=\"nowrap\">",
"       cm/sec",
"      </span>",
"      and 12",
"      <span class=\"nowrap\">",
"       cm/sec,",
"      </span>",
"      which is nondiagnostic.",
"     </li>",
"     <li>",
"      The Doppler myocardial velocity gradient, as measured from the left ventricular posterior wall in early diastole and during ventricular ejection, was significantly lower in patients with a restrictive cardiomyopathy compared to those with constrictive pericarditis and to normal controls.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiac catheterization &mdash; Right and left ventricular end-diastolic pressures (RVEDP and LVEDP) are equal or very nearly equal in constrictive pericarditis, while LVEDP is usually higher than RVEDP in restrictive cardiomyopathy. However, in many cases of restrictive cardiomyopathy the plateau of diastolic pressure is equally elevated in both ventricles as typically occurs in constrictive pericarditis. If the pressures are approximately equal, a fluid bolus, exercise, or pharmacologic maneuver should theoretically increase LVEDP above RVEDP in restrictive cardiomyopathy. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Cardiac catheterization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Biopsy &mdash; Endomyocardial, or less commonly, pericardial biopsy may be helpful when hemodynamic and imaging studies fail to establish the diagnosis. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Cardiac catheterization'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/1\">",
"      Francone M, Dymarkowski S, Kalantzi M, et al. Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy. Eur Radiol 2006; 16:944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/2\">",
"      Hatle LK, Appleton CP, Popp RL. Differentiation of constrictive pericarditis and restrictive cardiomyopathy by Doppler echocardiography. Circulation 1989; 79:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/3\">",
"      Oh JK, Hatle LK, Seward JB, et al. Diagnostic role of Doppler echocardiography in constrictive pericarditis. J Am Coll Cardiol 1994; 23:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/4\">",
"      Ling LH, Oh JK, Schaff HV, et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation 1999; 100:1380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/5\">",
"      Leya FS, Arab D, Joyal D, et al. The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. J Am Coll Cardiol 2005; 45:1900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/6\">",
"      Babuin L, Alegria JR, Oh JK, et al. Brain natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy. J Am Coll Cardiol 2006; 47:1489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/7\">",
"      Sengupta PP, Krishnamoorthy VK, Abhayaratna WP, et al. Comparison of usefulness of tissue Doppler imaging versus brain natriuretic peptide for differentiation of constrictive pericardial disease from restrictive cardiomyopathy. Am J Cardiol 2008; 102:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/8\">",
"      Ling LH, Oh JK, Breen JF, et al. Calcific constrictive pericarditis: is it still with us? Ann Intern Med 2000; 132:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/9\">",
"      Talreja DR, Edwards WD, Danielson GK, et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation 2003; 108:1852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/10\">",
"      Masui T, Finck S, Higgins CB. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology 1992; 182:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/11\">",
"      Rajagopalan N, Garcia MJ, Rodriguez L, et al. Comparison of new Doppler echocardiographic methods to differentiate constrictive pericardial heart disease and restrictive cardiomyopathy. Am J Cardiol 2001; 87:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/12\">",
"      Ha JW, Oh JK, Ling LH, et al. Annulus paradoxus: transmitral flow velocity to mitral annular velocity ratio is inversely proportional to pulmonary capillary wedge pressure in patients with constrictive pericarditis. Circulation 2001; 104:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/13\">",
"      Tabata T, Kabbani SS, Murray RD, et al. Difference in the respiratory variation between pulmonary venous and mitral inflow Doppler velocities in patients with constrictive pericarditis with and without atrial fibrillation. J Am Coll Cardiol 2001; 37:1936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/14\">",
"      Boonyaratavej S, Oh JK, Tajik AJ, et al. Comparison of mitral inflow and superior vena cava Doppler velocities in chronic obstructive pulmonary disease and constrictive pericarditis. J Am Coll Cardiol 1998; 32:2043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/15\">",
"      Palka P, Lange A, Donnelly JE, Nihoyannopoulos P. Differentiation between restrictive cardiomyopathy and constrictive pericarditis by early diastolic doppler myocardial velocity gradient at the posterior wall. Circulation 2000; 102:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/16\">",
"      Choi EY, Ha JW, Kim JM, et al. Incremental value of combining systolic mitral annular velocity and time difference between mitral inflow and diastolic mitral annular velocity to early diastolic annular velocity for differentiating constrictive pericarditis from restrictive cardiomyopathy. J Am Soc Echocardiogr 2007; 20:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/17\">",
"      MCHENRY MM, ORD JW, JOHNSTON RR, SHOENER JA. EXERCISE PERFORMANCE AND STROKE VOLUME CHANGES IN TWO PATIENTS WITH CONSTRICTIVE PERICARDITIS. Am Heart J 1965; 70:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/18\">",
"      Nakhjavan FK, Goldberg H. Hemodynamic effects of catecholamine stimulation in constrictive pericarditis. Circulation 1970; 42:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/19\">",
"      Tyberg TI, Goodyer AV, Hurst VW 3rd, et al. Left ventricular filling in differentiating restrictive amyloid cardiomyopathy and constrictive pericarditis. Am J Cardiol 1981; 47:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/20\">",
"      Talreja DR, Nishimura RA, Oh JK, Holmes DR. Constrictive pericarditis in the modern era: novel criteria for diagnosis in the cardiac catheterization laboratory. J Am Coll Cardiol 2008; 51:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/21\">",
"      HANSEN AT, ESKILDSEN P, GOTZSCHE H. Pressure curves from the right auricle and the right ventricle in chronic constrictive pericarditis. Circulation 1951; 3:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/22\">",
"      Hirota Y, Kohriyama T, Hayashi T, et al. Idiopathic restrictive cardiomyopathy: differences of left ventricular relaxation and diastolic wave forms from constrictive pericarditis. Am J Cardiol 1983; 52:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/23\">",
"      Meaney E, Shabetai R, Bhargava V, et al. Cardiac amyloidosis, contrictive pericarditis and restrictive cardiomyopathy. Am J Cardiol 1976; 38:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/24\">",
"      Hurrell DG, Nishimura RA, Higano ST, et al. Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis. Circulation 1996; 93:2007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/25\">",
"      Schoenfeld MH, Supple EW, Dec GW Jr, et al. Restrictive cardiomyopathy versus constrictive pericarditis: role of endomyocardial biopsy in avoiding unnecessary thoracotomy. Circulation 1987; 75:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29752/abstract/26\">",
"      Maisch B, Bethge C, Drude L, et al. Pericardioscopy and epicardial biopsy--new diagnostic tools in pericardial and perimyocardial disease. Eur Heart J 1994; 15 Suppl C:68.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4946 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-83.177.194.223-77399545CD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29752=[""].join("\n");
var outline_f29_3_29752=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18190864\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30200245\">",
"      PATHOPHYSIOLOGY OF RESPIRATORY EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORY AND PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      NON-INVASIVE TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H740032\">",
"      Plasma BNP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Chest x-ray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Pericardial imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Doppler echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Tissue Doppler imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CARDIAC CATHETERIZATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18190864\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/4946\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4946|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/18/12578\" title=\"diagnostic image 1\">",
"      Lateral CXR showing pericardial calcium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/40/11911\" title=\"diagnostic image 2\">",
"      EBCT in pericardial disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/13/20692\" title=\"diagnostic image 3\">",
"      Doppler echo cardiac tamponade",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4946|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/1/40976\" title=\"figure 1\">",
"      Jugular venous pulse in constrictive pericarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/59/7097\" title=\"figure 2\">",
"      Dip and plateau in constrictive pericarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/48/44801\" title=\"figure 3\">",
"      Resp change const peri",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4946|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?5/31/5618\" title=\"waveform 1A\">",
"      Doppler transmitral inflow pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?31/45/32470\" title=\"waveform 1B\">",
"      Doppler diastolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?33/50/34597\" title=\"waveform 2\">",
"      Pulse wave Doppler COPD constr",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?22/35/23093\" title=\"waveform 3\">",
"      TDE constriction v restriction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?26/10/26786\" title=\"waveform 4\">",
"      Hemodynamics in constriction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17722?source=related_link\">",
"      Cardiac sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/21/34137?source=related_link\">",
"      Cardiotoxicity of radiation therapy for malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/10/23722?source=related_link\">",
"      Clinical manifestations and diagnosis of amyloid cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12490?source=related_link\">",
"      Constrictive pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/43/30392?source=related_link\">",
"      Etiology of pericardial disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/59/33719?source=related_link\">",
"      Examination of the jugular venous pulse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23207?source=related_link\">",
"      Idiopathic restrictive cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19818?source=related_link\">",
"      Natriuretic peptide measurement in heart failure",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_3_29753="Zinc deficiency and supplementation in children and adolescents";
var content_f29_3_29753=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Zinc deficiency and supplementation in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/3/29753/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/3/29753/contributors\">",
"     Steven A Abrams, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/3/29753/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/3/29753/contributors\">",
"     Kathleen J Motil, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/3/29753/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/3/29753/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?29/3/29753/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Zinc is an essential trace element. Zinc intake is closely related to protein intake; as a result, it is an important component of nutritionally related morbidity worldwide. Symptoms attributable to severe zinc depletion include growth failure, primary hypogonadism, skin disease, impaired taste and smell, and impaired immunity and resistance to infection. Zinc supplementation in populations likely at risk for zinc deficiency appears to have beneficial effects on the incidence and outcome of serious childhood infectious diseases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ZINC METABOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 10 to 40 percent of dietary zinc is absorbed in the small bowel; absorption is inhibited by the presence of phytates and fiber in the diet that bind to zinc, as well as dietary iron and cadmium [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/1\">",
"     1",
"    </a>",
"    ]. Nonetheless, a randomized trial showed that standard iron supplements did not significantly interfere with zinc absorption or reduce zinc levels in healthy breastfed infants [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/2\">",
"     2",
"    </a>",
"    ]. Approximately 0.5 to 1.0",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    is secreted in the biliary tract and excreted in the stool.",
"   </p>",
"   <p>",
"    Zinc circulates at a concentration of 70 to 120",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    with 60 percent loosely bound to albumin and 30 percent tightly bound to macroglobulin. Urinary excretion typically ranges from 0.5 to 0.8",
"    <span class=\"nowrap\">",
"     mg/day.",
"    </span>",
"    The primary stores of zinc include the liver and kidney. Most of the body zinc stores are intracellular where zinc is bound to metalloproteins.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Zinc is the intrinsic metal component or activating cofactor for more than 70 important enzyme systems, including carbonic anhydrase, the alkaline phosphatases, dehydrogenases, and carboxypeptidases. It is involved in the regulation of nucleoproteins and the activity of various inflammatory cells and plays a role in growth, tissue repair and wound healing, carbohydrate tolerance, and synthesis of testicular hormones.",
"   </p>",
"   <p>",
"    Zinc is involved in the immune response and the response to infection. Zinc deficiency is associated with impaired phagocytic function, lymphocyte depletion, decreased immunoglobulin production, a reduction in the",
"    <span class=\"nowrap\">",
"     T4+/T8+",
"    </span>",
"    ratio, and decreased interleukin (IL)-2 production [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Emerging evidence suggests that zinc may have specific inhibitory effects on some pathogens. As examples, zinc appears to block the secretory effects of cholera toxin and E. coli heat-labile enterotoxin [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/6\">",
"     6",
"    </a>",
"    ], and has direct inhibitory effects on enteropathogenic E. coli [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/7\">",
"     7",
"    </a>",
"    ]. Such effects appear to be due to local rather than systemic effects of the zinc [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12503302\">",
"    <span class=\"h1\">",
"     RECOMMENDED INTAKE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual oral intake of zinc is approximately 4 to 14",
"    <span class=\"nowrap\">",
"     mg/day;",
"    </span>",
"    the recommended dietary allowance (RDA) is 8",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for children ages 9 to 11 years; the RDA for adolescent and adult males is 11",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    (",
"    <a class=\"graphic graphic_table graphicRef51953 \" href=\"UTD.htm?37/22/38241\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/9\">",
"     9",
"    </a>",
"    ]. Primary dietary sources of zinc include animal products such as meat, seafood, and milk (",
"    <a class=\"graphic graphic_table graphicRef53710 \" href=\"UTD.htm?28/23/29052\">",
"     table 2",
"    </a>",
"    ). Ready-to-eat cereal contains the greatest amount of zinc consumed from plant products [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/10\">",
"     10",
"    </a>",
"    ]. Sufficient dietary zinc sources are available in a typical mixed diet, but lacto-ovo-vegetarians need more milk, eggs, grains, legumes, nuts, and seeds to achieve adequate levels [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=see_link\">",
"     \"Vegetarian diets for children\"",
"    </a>",
"    .) &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ZINC DEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Zinc deficiency is an important problem in children and adolescents, particularly in developing countries. The true prevalence of mild zinc deficiency is not known because of the nonspecificity of symptoms and imprecise diagnostic methods.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Dietary zinc depletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Zinc depletion was first described as a consequence of poor intake in adolescent males in Iran and Egypt [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/13\">",
"     13",
"    </a>",
"    ]. The depletion was caused by both inadequate zinc intake and the binding of ingested zinc to fiber and phytates in unleavened bread and clay. Affected patients suffered from severe growth retardation, anemia, hypogonadism, rough skin, and apathy or general lethargy. The growth retardation and hypogonadism responded to zinc supplementation.",
"   </p>",
"   <p>",
"    Experimental zinc deficiency has been produced in normal volunteers [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/14\">",
"     14",
"    </a>",
"    ]. They developed primary hypogonadism with decreased serum androgens, increased serum gonadotropins, and oligospermia.",
"   </p>",
"   <p>",
"    Inadequate dietary zinc intake and depletion is thought to be an important worldwide health problem affecting poor children in developing countries. Both breast milk and the complementary foods typically offered in developing countries provide inadequate amounts of zinc [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/15\">",
"     15",
"    </a>",
"    ]. The potential significance of this condition has been studied in randomized supplementation trials. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Zinc supplementation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Local non-fortified foods may prove to be an important solution to dietary zinc depletion and its health consequences. In particular, the use of meat and liver as a first food for infants may provide a practical solution for infants in developing countries [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/15\">",
"     15",
"    </a>",
"    ]. This approach was explored in two studies of healthy breastfed infants in the United States, in which infants were randomized to be fed with either fortified cereal or beef as a first complementary food from age 4 to 7 months [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Both diets provided estimated requirements of zinc and iron, and there were no differences in infant tolerance or acceptance, or in serum zinc levels. These findings suggest that meat or liver may provide a practical solution to zinc and iron deficiency in developing countries, if social, cultural, and economic barriers to this practice can be addressed by public health initiatives.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Breastfeeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic zinc deficiency occurs rarely in exclusively breast-fed infants (usually premature) whose mothers have a low level of zinc in their breast milk. The clinical presentation is similar to that of acrodermatitis enteropathica (see next section) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/18-21\">",
"     18-21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Acrodermatitis enteropathica",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acrodermatitis enteropathica is a recessively inherited partial defect in intestinal zinc absorption. It is the result of mutations in the SLC39A4 gene on chromosome 8q24.3, which encodes a protein that appears to be involved in zinc transportation [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Affected infants develop an erythematous and vesiculobullous dermatitis (",
"    <a class=\"graphic graphic_picture graphicRef71329 \" href=\"UTD.htm?39/34/40481\">",
"     picture 1",
"    </a>",
"    ), alopecia, ophthalmic disorders, diarrhea, severe growth retardation, delayed sexual maturation, neuropsychiatric manifestations, and frequent infections. The syndrome is associated with severe zinc depletion and responds to oral supplementation with pharmacologic doses of zinc. Replacement doses of 3",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    of elemental zinc (13.2",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/39/29301?source=see_link\">",
"     zinc sulfate",
"    </a>",
"    ) are recommended; zinc levels are measured every three to six months and the dose is adjusted up or down as needed [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reduced zinc levels, at times symptomatic, have been reported in several other conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Crohn disease &ndash; Low plasma zinc concentrations occur in a significant number of patients with active Crohn disease [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/26\">",
"       26",
"      </a>",
"      ]. The clinical significance of this observation is not known. Several cases of dermatitis resembling acrodermatitis enteropathica with alopecia and eczematous changes responding to zinc administration have been described [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/27-29\">",
"       27-29",
"      </a>",
"      ]. Hypogonadism, growth retardation, and abnormalities in taste also have been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/27\">",
"       27",
"      </a>",
"      ]. Studies have suggested that zinc absorption is significantly reduced in children with Crohn disease, whereas endogenous fecal zinc excretion and urinary zinc excretion are unchanged [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/30\">",
"       30",
"      </a>",
"      ]. This results in much poorer zinc balance in the children with Crohn disease. The long-term consequences of this and the optimum level of zinc supplementation for children with Crohn disease remain unclear. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/47/41722?source=see_link&amp;anchor=H29#H29\">",
"       \"Overview of the management of Crohn's disease in children and adolescents\", section on 'Monitoring nutritional status'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cystic fibrosis &ndash; Dermatitis caused by zinc deficiency can be a presenting feature of cystic fibrosis in infants [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/31-33\">",
"       31-33",
"      </a>",
"      ]. The dermatitis resembles acrodermatitis enteropathica but may be more widespread and may not respond to zinc supplementation alone [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/34\">",
"       34",
"      </a>",
"      ]. Concomitant deficiencies in essential fatty acids or",
"      <span class=\"nowrap\">",
"       protein/energy",
"      </span>",
"      malnutrition also may contribute to the dermatitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=see_link\">",
"       \"Cystic fibrosis: Nutritional issues\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sickle cell disease &ndash; Low zinc levels can occur in children and adolescents with sickle cell disease, particularly in association with poor or delayed growth [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]. Zinc depletion in this population appears to reflect increased urinary excretion caused by a renal tubular defect and perhaps chronic hemolysis or impaired absorption, not inadequate dietary intake [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/36,37\">",
"       36,37",
"      </a>",
"      ]. In one study, for example, 44 percent of 104 children with sickle cell disease had low plasma zinc concentrations [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/35\">",
"       35",
"      </a>",
"      ]. These children, when compared to those with normal plasma zinc levels, had significant reductions in height, weight, upper arm muscle area, and, in older children, delayed sexual maturation. Whether zinc deficiency promotes infection in children with sickle cell disease remains controversial [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Liver disease &ndash; Children and adults with severe, chronic liver disease have an increased incidence of low plasma zinc levels [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/39-41\">",
"       39-41",
"      </a>",
"      ]. The mechanism may be multifactorial, including hypoalbuminemia, reduced intake, and increased urinary excretion. The low plasma concentration and the increased urinary excretion correct within seven days of liver transplantation [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/39,40\">",
"       39,40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Inadequate zinc supplementation in parenteral nutrition &ndash; A case series described three premature infants with cholestasis who developed clinical zinc deficiency consisting of diaper dermatitis, perioral erosions, and bullae on the dorsal surface of the hands and feet [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/42\">",
"       42",
"      </a>",
"      ]. The infants had received prolonged parenteral nutrition with inadequate zinc supplementation due to a nationwide shortage of injectable zinc in 2012. Premature infants have increased needs for zinc because of low body stores and increased requirements for growth (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/50/27434?source=see_link&amp;anchor=H26#H26\">",
"       \"Parenteral nutrition in premature infants\", section on 'Trace elements'",
"      </a>",
"      ). The shortage of zinc for parenteral administration remains a concern in the United States and elsewhere; clinicians should maintain vigilance in children of all ages receiving parenteral nutrition because of the possibility of zinc deficiency. &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Renal disease &ndash; Zinc deficiency caused by increased urinary excretion can complicate nephrotic syndrome in children [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/43\">",
"       43",
"      </a>",
"      ]. In addition, uremic patients are often deficient in zinc, probably because of reduced dietary intake, zinc malabsorption,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      possible leaching of zinc by dialysis equipment [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/44,45\">",
"       44,45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Adolescent athletes &ndash; One study found significantly low plasma zinc concentrations in adolescent gymnasts when compared to matched control sedentary children [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/46\">",
"       46",
"      </a>",
"      ]. This finding probably is related to inadequate intake associated with overall dietary restrictions caused by a desire to maintain weight as well as possibly increased losses in sweat. Other studies have not found reduced zinc levels in adolescent athletes with normal zinc intakes [",
"      <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/47,48\">",
"       47,48",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous signs and symptoms have been associated with zinc depletion (",
"    <a class=\"graphic graphic_table graphicRef55126 \" href=\"UTD.htm?40/7/41083\">",
"     table 3",
"    </a>",
"    ). Mild zinc deficiency is associated with depressed immunity, impaired taste and smell, onset of night blindness, and decreased spermatogenesis. Severe zinc deficiency is characterized by severely depressed immune function, frequent infections, bullous pustular dermatitis, diarrhea, and alopecia (",
"    <a class=\"graphic graphic_picture graphicRef59027 \" href=\"UTD.htm?4/3/4145\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/3,4,49\">",
"     3,4,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some situations, zinc depletion is documented by measurement of zinc concentration in plasma, lymphocytes, or neutrophils. Because zinc is a cofactor for alkaline phosphatase activity, alkaline phosphatase serves as a serologic marker for zinc depletion [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/50\">",
"     50",
"    </a>",
"    ]. In other situations, the diagnosis of zinc depletion is inferred by the response to zinc supplementation in placebo-controlled intervention. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Zinc supplementation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Zinc status can be assessed by measurement of zinc in plasma, erythrocytes, neutrophils, lymphocytes, and hair. Measurement of zinc in the plasma is simple and readily available in many laboratories. A low plasma zinc usually is defined as a value less than 60",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/51\">",
"     51",
"    </a>",
"    ]. Because most plasma zinc is bound to albumin, measured zinc levels will typically be reduced in patients with hypoalbuminemia. However, in clinical practice, it is not particularly helpful to correct measured zinc levels for hypoalbuminemia, because plasma levels are only loosely correlated with zinc stores, and because zinc replacement is usually provided to patients with low zinc levels, regardless of albumin status, particularly in the context of chronic disease.",
"   </p>",
"   <p>",
"    Some investigators argue that plasma zinc measurements are relatively insensitive and that mild zinc deficiency occurs with normal plasma levels [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/52\">",
"     52",
"    </a>",
"    ]. Zinc levels in neutrophils or lymphocytes may be more sensitive [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/53\">",
"     53",
"    </a>",
"    ]. The criteria for zinc deficiency are decreased zinc level in either lymphocytes (&lt;50",
"    <span class=\"nowrap\">",
"     mcg/10(10)",
"    </span>",
"    cells) or granulocytes (&lt;42",
"    <span class=\"nowrap\">",
"     mcg/10(10)",
"    </span>",
"    cells) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/54\">",
"     54",
"    </a>",
"    ]. Depressed serum alkaline phosphatase levels for age provide supportive evidence for zinc deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ZINC SUPPLEMENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Zinc deficiency, associated with impaired immunity and propensity to infection, is thought to be common in children in developing countries in which children experience high rates of serious infections. Zinc supplementation has been evaluated both as a therapeutic agent and as a potential prophylactic agent in children in these populations [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Prevention of diarrhea and pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous studies in developing countries have shown that routine oral zinc supplementation reduces the incidence of diarrheal disease and pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/55-61\">",
"     55-61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a meta-analysis, zinc supplementation for three or more months in children younger than 5 years of age reduced episodes of diarrhea, respiratory tract infections, severe diarrhea or dysentery, persistent diarrhea, and lower respiratory tract infections or pneumonias, with rate ratios between 0.75 and 0.95 [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/60\">",
"     60",
"    </a>",
"    ]. The effect size is small and probably enhanced by publication bias, suggesting that it would be helpful to identify subpopulations most likely to benefit from zinc supplementation. Two other meta-analyses that included several of the same trials found that zinc supplementation given to children between two and five years of age in developing countries reduced the incidence of clinically confirmed pneumonia by about 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/61,62\">",
"     61,62",
"    </a>",
"    ], and of diarrhea by 13 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/61\">",
"     61",
"    </a>",
"    ]. The doses of elemental zinc used in the studies included in these meta-analyses ranged from 15 to 140",
"    <span class=\"nowrap\">",
"     mg/week.",
"    </span>",
"    A randomized trial in Africa found that adjunctive treatment with a multivitamin supplement did not enhance the efficacy of zinc supplementation in preventing diarrheal episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/63\">",
"     63",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    One placebo controlled study described outcomes of zinc supplementation during the neonatal period. Brazilian infants with low birth weight were given 5 mg",
"    <span class=\"nowrap\">",
"     zinc/day",
"    </span>",
"    or placebo for the first eight weeks of life. Infants who received zinc supplement had 48 percent less diarrhea than did a control group during their initial 26 weeks of life [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Zinc supplementation given to pregnant women reduces the frequency of diarrhea during infancy in their offspring. In a placebo-controlled trial in Peru, infants whose mothers received prenatal zinc supplementation had a 34 percent lower risk of prolonged diarrheal episodes as compared to controls [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Treatment of acute diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several randomized studies have examined the effects of zinc supplementation for children with acute diarrhea in developing countries [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/55,56,66-71\">",
"     55,56,66-71",
"    </a>",
"    ]. In the largest of these trials, 937 Indian children between the ages of 6 and 35 months with acute diarrhea received vitamin supplementation and were randomly assigned to receive placebo or 20 mg of zinc per day [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/67\">",
"     67",
"    </a>",
"    ]. Children with malnutrition severe enough to require hospitalization were excluded. Zinc supplementation reduced the duration of diarrhea by 23 percent (95% CI 12-32 percent) and the number of watery stools per day by 39 percent (95% CI 6-70 percent). The reductions in duration and severity were greater in children with growth retardation than in those with normal growth. This observation has been confirmed in other studies [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although similar effects have not been demonstrated in all populations, the preponderance of evidence suggests that zinc supplementation reduces the severity and duration of acute diarrhea in children from populations in which zinc deficiency is common [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/72-74\">",
"     72-74",
"    </a>",
"    ]. Based on these findings, the WHO recommends zinc supplementation for infants and children with acute diarrhea in developing countries [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/73,75\">",
"     73,75",
"    </a>",
"    ]. The supplements are given at a dose of 20",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for children, or 10",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for infants younger than 6 months old, for 10 to 14 days.",
"   </p>",
"   <p>",
"    Zinc supplementation is probably helpful for treatment of acute diarrhea even in populations without zinc deficiency. A metaanalysis of 18 randomized trials concluded that the subgroup without zinc deficiency also benefitted from zinc supplementation [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/71\">",
"     71",
"    </a>",
"    ]. This may be because zinc has specific local inhibitory effects on some enteric pathogens and toxins [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Actions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Intestinal absorption of copper is inhibited by zinc. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Zinc toxicity'",
"    </a>",
"    below.) One randomized trial of zinc administration to malnourished children with persistent diarrhea, using doses of 3",
"    <span class=\"nowrap\">",
"     mg/kg/day,",
"    </span>",
"    raised concern that zinc supplementation may reduce serum copper levels [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/76\">",
"     76",
"    </a>",
"    ]. However, a different randomized trial using doses of 10",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for four months showed that zinc supplementation did not affect serum copper levels [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/77\">",
"     77",
"    </a>",
"    ]. The population in the second study was younger (infants &lt;4 months of age) and may have had lesser degrees of malnutrition. In a third randomized trial, zinc given at higher doses (15 mg daily for infants &lt;12 months and 30 mg daily for those &gt;12 months) for 14 days also did not affect copper levels [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/78\">",
"     78",
"    </a>",
"    ]. The weight of the evidence supports the WHO guidelines for supplementation, but further research into the possibility of copper deficiency is needed to determine the optimal dose and length of treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Treatment of persistent diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;The World Health Organization defines diarrheal episodes of greater than 14 days as persistent diarrhea. Persistent diarrhea is associated with higher mortality and greater adverse growth effects than is acute diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/79\">",
"     79",
"    </a>",
"    ]. Randomized, controlled trials in children with persistent diarrhea have generally shown that zinc supplementation reduces the severity and duration of acute and persistent diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/59,71,72,74,80,81\">",
"     59,71,72,74,80,81",
"    </a>",
"    ]. Based on these findings, the WHO recommends zinc supplementation for children with diarrhea in developing countries, at a dose of 10 mg daily for infants up to 6 months of age, and 20 mg daily for older infants and children, for 14 days [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/75\">",
"     75",
"    </a>",
"    ]. Despite these recommendations, only a small percentage of children with diarrhea in high-burden countries receive zinc supplementation for diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/82,83\">",
"     82,83",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/37/43609?source=see_link\">",
"     \"Persistent diarrhea in children in developing countries\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9661506\">",
"    <span class=\"h2\">",
"     Adjunctive treatment for bacterial infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Zinc supplementation appears to be helpful as an adjunct to antibiotic treatment of young infants with probable serious bacterial infection. This was shown in a large randomized trial in 700 infants aged 7 to 120 days presenting in India with signs and symptoms of serious bacterial infection, including pneumonia, sepsis, and diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/84\">",
"     84",
"    </a>",
"    ]. All subjects were treated with antibiotics according to a standardized protocol. Infants who were also treated with zinc (5 mg twice daily by mouth) had significantly less treatment failure as compared to those treated with placebo (10 percent versus 17 percent); treatment failure was defined as a need to change antibiotics within seven days of randomization, or a need for intensive care, or death at any time within 21 days. The absolute risk reduction was 6.8 percent (95% CI 1.5-12.0). The population in this study has a high rate of underlying nutritional zinc deficiency, and whether adjunctive zinc treatment for bacterial infection is beneficial in other populations has not been established. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28556119\">",
"    <span class=\"h2\">",
"     Enhancement of growth",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some studies have described improved linear growth in infants who receive zinc supplementation, especially in those who were stunted or had low plasma zinc concentrations at baseline [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/85-90\">",
"     85-90",
"    </a>",
"    ]. A meta-analysis of 33 randomized controlled trials confirmed the effects of zinc supplementation in enhancing linear growth and weight gain in children with growth retardation [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/91\">",
"     91",
"    </a>",
"    ]. The doses of zinc used in these trials varied from 1 to 20",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    of elemental zinc. Because zinc has no pharmacologic effect on growth, a growth response to zinc is taken as evidence of a preceding growth-limiting zinc deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Prevention or treatment of malaria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trials examining whether zinc supplementation reduces morbidity or mortality from malaria have had conflicting results. A randomized trial in Papua, New Guinea showed that supplementation reduced clinic visits for malaria [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/93\">",
"     93",
"    </a>",
"    ]. Several other trials reported non-significant reductions of morbidity from malaria [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/85,93,94\">",
"     85,93,94",
"    </a>",
"    ]. A large placebo-controlled trial performed in a malaria-endemic area of Africa also failed to show a significant effect of zinc supplementation on overall mortality or malaria-related mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/95\">",
"     95",
"    </a>",
"    ]. However, the analysis raised the possibility that there may be benefit in subgroups of children. Zinc levels tend to decrease during the acute phase response in children with falciparum malaria [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/96\">",
"     96",
"    </a>",
"    ]. However, zinc supplementation does not appear to have a beneficial effect when used as an adjunct to treatment of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/97,98\">",
"     97,98",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25241?source=see_link\">",
"     \"Treatment of uncomplicated falciparum malaria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13338?source=see_link\">",
"     \"Treatment of severe falciparum malaria\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Treatment of the common cold",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial studies suggested that zinc lozenges could shorten the duration of symptoms of the common cold [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/99,100\">",
"     99,100",
"    </a>",
"    ]. However, another controlled trial and a meta-analysis reviewing six trials found no benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/101,102\">",
"     101,102",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13146?source=see_link&amp;anchor=H15314143#H15314143\">",
"     \"The common cold in children: Treatment and prevention\", section on 'Zinc'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     ZINC TOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Little toxicity occurs with zinc supplementation. Ingestion of up to ten times the recommended daily intake produces no symptoms. Intestinal absorption of copper is inhibited by zinc. Thus, chronic intake of high doses of zinc may be associated with copper deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/103\">",
"     103",
"    </a>",
"    ]. This concern is the main basis for the upper tolerable limits (UL) for zinc established by the Food and Nutrition Board, which range from 4",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    in young infants to 40",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    in adults (",
"    <a class=\"graphic graphic_table graphicRef51953 \" href=\"UTD.htm?37/22/38241\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/9\">",
"     9",
"    </a>",
"    ]. Note that this UL refers to chronic intake of zinc and does not preclude the acute use of higher doses of zinc for treatment of deficiency or diarrhea. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39226?source=see_link&amp;anchor=H58#H58\">",
"     \"Overview of dietary trace minerals\", section on 'Zinc'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The acute ingestion of 1 to 2 g",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/39/29301?source=see_link\">",
"     zinc sulfate",
"    </a>",
"    produces nausea and vomiting associated with irritation and corrosion of the gastrointestinal tract. Large doses of zinc compounds also can produce acute renal failure caused by tubular necrosis or interstitial nephritis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/3/29753/abstract/104\">",
"     104",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/53/19290?source=see_link\">",
"     \"Acute kidney injury in children: Clinical features, etiology, evaluation, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28555722\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Because zinc intake is closely related to protein intake, zinc deficiency is an important component of nutritionally related morbidity worldwide. Primary dietary sources of zinc include animal products such as meat, seafood, milk and fortified cereal (",
"      <a class=\"graphic graphic_table graphicRef53710 \" href=\"UTD.htm?28/23/29052\">",
"       table 2",
"      </a>",
"      ). Sufficient dietary zinc sources are available in a typical mixed diet, but lacto-ovo-vegetarians need more milk, eggs, grains, legumes, nuts, and seeds to achieve adequate levels. (See",
"      <a class=\"local\" href=\"#H12503302\">",
"       'Recommended intake'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms attributable to severe zinc depletion include growth failure, primary hypogonadism, skin disease, impaired taste and smell, and impaired immunity and resistance to infection. Severe zinc deficiency is characterized by severely depressed immune function, frequent infections, bullous pustular dermatitis, diarrhea, and alopecia (",
"      <a class=\"graphic graphic_picture graphicRef59027 \" href=\"UTD.htm?4/3/4145\">",
"       picture 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Inadequate dietary zinc intake and depletion is thought to be an important worldwide health problem affecting poor children in developing countries. Both breast milk and the complementary foods typically offered in developing countries provide inadequate amounts of zinc. Symptomatic zinc deficiency occasionally occurs in exclusively breast-fed infants (usually premature) whose mothers have a low level of zinc in their breast milk.",
"     </li>",
"     <li>",
"      Acrodermatitis enteropathica is a recessively inherited partial defect in intestinal zinc absorption. Affected infants develop an erythematous and vesiculobullous dermatitis (",
"      <a class=\"graphic graphic_picture graphicRef71329 \" href=\"UTD.htm?39/34/40481\">",
"       picture 1",
"      </a>",
"      ), alopecia, ophthalmic disorders, diarrhea, and severe growth retardation. The syndrome responds to oral supplementation with pharmacologic doses of zinc. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Acrodermatitis enteropathica'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Measurement of zinc in the plasma is readily available in many laboratories. A low plasma zinc usually is defined as a value less than 60",
"      <span class=\"nowrap\">",
"       mcg/dL.",
"      </span>",
"      Because much of plasma zinc is bound to albumin, zinc levels will be somewhat reduced in patients with hypoalbuminemia. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      above.) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Zinc deficiency is common in children in developing countries, and zinc deficiency appears to contribute to the risk of developing diarrhea and pneumonia. Routine oral zinc supplementation reduces the incidence of these disorders, and probably also enhances growth. Zinc supplementation also reduces the severity and duration of acute diarrhea in children from populations in which zinc deficiency is common. There is less evidence that zinc supplementation is useful for prevention or treatment of malaria or of the common cold. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Zinc supplementation'",
"      </a>",
"      above.) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Little toxicity occurs with zinc supplementation. Ingestion of up to ten times the recommended daily intake produces no symptoms. Intestinal absorption of copper is inhibited by zinc. Thus, chronic intake of zinc in excess of 100 mg per day may be associated with copper deficiency. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Zinc toxicity'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/1\">",
"      L&ouml;nnerdal B. Dietary factors influencing zinc absorption. J Nutr 2000; 130:1378S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/2\">",
"      Domell&ouml;f M, Hernell O, Abrams SA, et al. Iron supplementation does not affect copper and zinc absorption in breastfed infants. Am J Clin Nutr 2009; 89:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/3\">",
"      Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 1998; 68:447S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/4\">",
"      Prasad AS. Zinc and immunity. Mol Cell Biochem 1998; 188:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/5\">",
"      Prasad AS, Meftah S, Abdallah J, et al. Serum thymulin in human zinc deficiency. J Clin Invest 1988; 82:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/6\">",
"      Canani RB, Cirillo P, Buccigrossi V, et al. Zinc inhibits cholera toxin-induced, but not Escherichia coli heat-stable enterotoxin-induced, ion secretion in human enterocytes. J Infect Dis 2005; 191:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/7\">",
"      Crane JK, Naeher TM, Shulgina I, et al. Effect of zinc in enteropathogenic Escherichia coli infection. Infect Immun 2007; 75:5974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/8\">",
"      Crane JK, Hoque KM. Zinc for infectious diarrhea in developed countries: should we be sprinkling our own lawns? J Pediatr Gastroenterol Nutr 2008; 46:484.",
"     </a>",
"    </li>",
"    <li>",
"     Food and Nutrition Board of the Institute of Medicine. Iron. In: Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and Zinc, National Academy Press, Washington DC 2000. p.24.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/10\">",
"      Subar AF, Krebs-Smith SM, Cook A, Kahle LL. Dietary sources of nutrients among US children, 1989-1991. Pediatrics 1998; 102:913.",
"     </a>",
"    </li>",
"    <li>",
"     Food and Nutrition Board. Recommended Dietary Allowances, 10th ed, National Academy Press, Washington DC 1989.",
"    </li>",
"    <li>",
"     Pennington JA. Food Values of Portions Commonly Used, 7th ed, Lippincott, Philadelphia 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/13\">",
"      PRASAD AS, MIALE A Jr, FARID Z, et al. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypognadism. J Lab Clin Med 1963; 61:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/14\">",
"      Abbasi AA, Prasad AS, Rabbani P, DuMouchelle E. Experimental zinc deficiency in man. Effect on testicular function. J Lab Clin Med 1980; 96:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/15\">",
"      Hambidge KM, Krebs NF. Zinc deficiency: a special challenge. J Nutr 2007; 137:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/16\">",
"      Krebs NF, Westcott JE, Butler N, et al. Meat as a first complementary food for breastfed infants: feasibility and impact on zinc intake and status. J Pediatr Gastroenterol Nutr 2006; 42:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/17\">",
"      Krebs NF, Westcott JE, Culbertson DL, et al. Comparison of complementary feeding strategies to meet zinc requirements of older breastfed infants. Am J Clin Nutr 2012; 96:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/18\">",
"      Stevens J, Lubitz L. Symptomatic zinc deficiency in breast-fed term and premature infants. J Paediatr Child Health 1998; 34:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/19\">",
"      Piela Z, Szuber M, Mach B, Janniger CK. Zinc deficiency in exclusively breast-fed infants. Cutis 1998; 61:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/20\">",
"      Heinen F, Matern D, Pringsheim W, et al. Zinc deficiency in an exclusively breast-fed preterm infant. Eur J Pediatr 1995; 154:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/21\">",
"      Kuramoto Y, Igarashi Y, Tagami H. Acquired zinc deficiency in breast-fed infants. Semin Dermatol 1991; 10:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/22\">",
"      K&uuml;ry S, Dr&eacute;no B, B&eacute;zieau S, et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet 2002; 31:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/23\">",
"      Wang K, Pugh EW, Griffen S, et al. Homozygosity mapping places the acrodermatitis enteropathica gene on chromosomal region 8q24.3. Am J Hum Genet 2001; 68:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/24\">",
"      Maverakis E, Fung MA, Lynch PJ, et al. Acrodermatitis enteropathica and an overview of zinc metabolism. J Am Acad Dermatol 2007; 56:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/25\">",
"      Neldner KH, Hambidge KM. Zinc therapy of acrodermatitis enteropathica. N Engl J Med 1975; 292:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/26\">",
"      Naber TH, van den Hamer CJ, Baadenhuysen H, Jansen JB. The value of methods to determine zinc deficiency in patients with Crohn's disease. Scand J Gastroenterol 1998; 33:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/27\">",
"      McClain C, Soutor C, Zieve L. Zinc deficiency: a complication of Crohn's disease. Gastroenterology 1980; 78:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/28\">",
"      Myung SJ, Yang SK, Jung HY, et al. Zinc deficiency manifested by dermatitis and visual dysfunction in a patient with Crohn's disease. J Gastroenterol 1998; 33:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/29\">",
"      Krasovec M, Frenk E. Acrodermatitis enteropathica secondary to Crohn's disease. Dermatology 1996; 193:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/30\">",
"      Griffin IJ, Kim SC, Hicks PD, et al. Zinc metabolism in adolescents with Crohn's disease. Pediatr Res 2004; 56:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/31\">",
"      Wenk KS, Higgins KB, Greer KE. Cystic fibrosis presenting with dermatitis. Arch Dermatol 2010; 146:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/32\">",
"      Bernstein ML, McCusker MM, Grant-Kels JM. Cutaneous manifestations of cystic fibrosis. Pediatr Dermatol 2008; 25:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/33\">",
"      Crone J, Huber WD, Eichler I, Granditsch G. Acrodermatitis enteropathica-like eruption as the presenting sign of cystic fibrosis--case report and review of the literature. Eur J Pediatr 2002; 161:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/34\">",
"      Darmstadt GL, Schmidt CP, Wechsler DS, et al. Dermatitis as a presenting sign of cystic fibrosis. Arch Dermatol 1992; 128:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/35\">",
"      Leonard MB, Zemel BS, Kawchak DA, et al. Plasma zinc status, growth, and maturation in children with sickle cell disease. J Pediatr 1998; 132:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/36\">",
"      Phebus CK, Maciak BJ, Gloninger MF, Paul HS. Zinc status of children with sickle cell disease: relationship to poor growth. Am J Hematol 1988; 29:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/37\">",
"      Yuzbasiyan-Gurkan VA, Brewer GJ, Vander AJ, et al. Net renal tubular reabsorption of zinc in healthy man and impaired handling in sickle cell anemia. Am J Hematol 1989; 31:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/38\">",
"      Prasad AS, Beck FW, Kaplan J, et al. Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD). Am J Hematol 1999; 61:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/39\">",
"      Narkewicz MR, Krebs N, Karrer F, et al. Correction of hypozincemia following liver transplantation in children is associated with reduced urinary zinc loss. Hepatology 1999; 29:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/40\">",
"      Pescovitz MD, Mehta PL, Jindal RM, et al. Zinc deficiency and its repletion following liver transplantation in humans. Clin Transplant 1996; 10:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/41\">",
"      Marchesini G, Bugianesi E, Ronchi M, et al. Zinc supplementation improves glucose disposal in patients with cirrhosis. Metabolism 1998; 47:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/42\">",
"      Centers for Disease Control and Prevention (CDC). Notes from the field: Zinc deficiency dermatitis in cholestatic extremely premature infants after a nationwide shortage of injectable zinc - Washington, DC, December 2012. MMWR Morb Mortal Wkly Rep 2013; 62:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/43\">",
"      Perrone L, Gialanella G, Giordano V, et al. Impaired zinc metabolic status in children affected by idiopathic nephrotic syndrome. Eur J Pediatr 1990; 149:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/44\">",
"      Mahajan SK, Bowersox EM, Rye DL, et al. Factors underlying abnormal zinc metabolism in uremia. Kidney Int Suppl 1989; 27:S269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/45\">",
"      Foote JW, Hinks LJ. Zinc absorption in haemodialysis patients. Ann Clin Biochem 1988; 25 ( Pt 4):398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/46\">",
"      Brun JF, Dieu-Cambrezy C, Charpiat A, et al. Serum zinc in highly trained adolescent gymnasts. Biol Trace Elem Res 1995; 47:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/47\">",
"      Fogelholm M, Rankinen T, Isok&auml;&auml;nt&auml; M, et al. Growth, dietary intake, and trace element status in pubescent athletes and schoolchildren. Med Sci Sports Exerc 2000; 32:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/48\">",
"      Rankinen T, Fogelholm M, Kujala U, et al. Dietary intake and nutritional status of athletic and nonathletic children in early puberty. Int J Sport Nutr 1995; 5:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/49\">",
"      Kay RG, Tasman-Jones C. Acute zinc deficency in man during intravenous alimentation. Aust N Z J Surg 1975; 45:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/50\">",
"      Kili&ccedil; I, Ozalp I, Co��kun T, et al. The effect of zinc-supplemented bread consumption on school children with asymptomatic zinc deficiency. J Pediatr Gastroenterol Nutr 1998; 26:167.",
"     </a>",
"    </li>",
"    <li>",
"     Hambidge KM, Casey CE, Krebs NF. Zinc. In: Trace elements in human and animal nutrition, Mertz W (Ed), Academic Press, Orlando 1986. p.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/52\">",
"      Wood RJ. Assessment of marginal zinc status in humans. J Nutr 2000; 130:1350S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/53\">",
"      Prasad AS, Cossack ZT. Zinc supplementation and growth in sickle cell disease. Ann Intern Med 1984; 100:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/54\">",
"      Meftah S, Prasad AS, Lee DY, Brewer GJ. Ecto 5' nucleotidase (5'NT) as a sensitive indicator of human zinc deficiency. J Lab Clin Med 1991; 118:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/55\">",
"      Black RE. Therapeutic and preventive effects of zinc on serious childhood infectious diseases in developing countries. Am J Clin Nutr 1998; 68:476S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/56\">",
"      Roy SK, Tomkins AM, Haider R, et al. Impact of zinc supplementation on subsequent growth and morbidity in Bangladeshi children with acute diarrhoea. Eur J Clin Nutr 1999; 53:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/57\">",
"      Sazawal S, Black RE, Jalla S, et al. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind, controlled trial. Pediatrics 1998; 102:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/58\">",
"      Brooks WA, Santosham M, Naheed A, et al. Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomised controlled trial. Lancet 2005; 366:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/59\">",
"      Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr 1999; 135:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/60\">",
"      Aggarwal R, Sentz J, Miller MA. Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-analysis. Pediatrics 2007; 119:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/61\">",
"      Yakoob MY, Theodoratou E, Jabeen A, et al. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC Public Health 2011; 11 Suppl 3:S23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/62\">",
"      Lassi ZS, Haider BA, Bhutta ZA. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 2010; :CD005978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/63\">",
"      Veenemans J, Schouten LR, Ottenhof MJ, et al. Effect of preventive supplementation with zinc and other micronutrients on non-malarial morbidity in Tanzanian pre-school children: a randomized trial. PLoS One 2012; 7:e41630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/64\">",
"      Lira PI, Ashworth A, Morris SS. Effect of zinc supplementation on the morbidity, immune function, and growth of low-birth-weight, full-term infants in northeast Brazil. Am J Clin Nutr 1998; 68:418S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/65\">",
"      Iannotti LL, Zavaleta N, Le&oacute;n Z, et al. Maternal zinc supplementation reduces diarrheal morbidity in peruvian infants. J Pediatr 2010; 156:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/66\">",
"      Sachdev HP, Mittal NK, Mittal SK, Yadav HS. A controlled trial on utility of oral zinc supplementation in acute dehydrating diarrhea in infants. J Pediatr Gastroenterol Nutr 1988; 7:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/67\">",
"      Sazawal S, Black RE, Bhan MK, et al. Zinc supplementation in young children with acute diarrhea in India. N Engl J Med 1995; 333:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/68\">",
"      Roy SK. Zinc supplementation in the treatment of childhood diarrhoea. Indian J Pediatr 1995; 62:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/69\">",
"      Roy SK, Tomkins AM, Akramuzzaman SM, et al. Randomised controlled trial of zinc supplementation in malnourished Bangladeshi children with acute diarrhoea. Arch Dis Child 1997; 77:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/70\">",
"      Faruque AS, Mahalanabis D, Haque SS, et al. Double-blind, randomized, controlled trial of zinc or vitamin A supplementation in young children with acute diarrhoea. Acta Paediatr 1999; 88:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/71\">",
"      Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev 2012; 6:CD005436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/72\">",
"      Bhutta ZA, Bird SM, Black RE, et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr 2000; 72:1516.",
"     </a>",
"    </li>",
"    <li>",
"     WHO/UNICEF Joint statement:  Clinical management of acute diarrhea. WHO/FCH/CAH/04.7. Geneva, 2004. Available at: file://www.emro.who.int/cah/pdf/who_unicef_statement.pdf (Accessed on October 19, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/74\">",
"      Lukacik M, Thomas RL, Aranda JV. A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea. Pediatrics 2008; 121:326.",
"     </a>",
"    </li>",
"    <li>",
"     WHO/CAH Diarrhoea treatment guidelines including new recommendations for the use of ORS and zinc supplementation for clinic-based healthcare workers. UNICEF, MOST, USAID, Geneva, 2005. file://www.mostproject.org/ZINC/Zinc_Updates_Apr05/Diarrhoeaguidelines.pdf (Accessed on October 19, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/76\">",
"      Bhutta ZA, Nizami SQ, Isani Z. Zinc supplementation in malnourished children with persistent diarrhea in Pakistan. Pediatrics 1999; 103:e42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/77\">",
"      Sazawal S, Malik P, Jalla S, et al. Zinc supplementation for four months does not affect plasma copper concentration in infants. Acta Paediatr 2004; 93:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/78\">",
"      Bhatnagar S, Bahl R, Sharma PK, et al. Zinc with oral rehydration therapy reduces stool output and duration of diarrhea in hospitalized children: a randomized controlled trial. J Pediatr Gastroenterol Nutr 2004; 38:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/79\">",
"      Black RE. Persistent diarrhea in children of developing countries. Pediatr Infect Dis J 1993; 12:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/80\">",
"      Roy SK, Tomkins AM, Mahalanabis D, et al. Impact of zinc supplementation on persistent diarrhoea in malnourished Bangladeshi children. Acta Paediatr 1998; 87:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/81\">",
"      Hoque KM, Binder HJ. Zinc in the treatment of acute diarrhea: current status and assessment. Gastroenterology 2006; 130:2201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/82\">",
"      Sabot O, Schroder K, Yamey G, Montagu D. Scaling up oral rehydration salts and zinc for the treatment of diarrhoea. BMJ 2012; 344:e940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/83\">",
"      Fischer Walker CL, Friberg IK, Binkin N, et al. Scaling up diarrhea prevention and treatment interventions: a Lives Saved Tool analysis. PLoS Med 2011; 8:e1000428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/84\">",
"      Bhatnagar S, Wadhwa N, Aneja S, et al. Zinc as adjunct treatment in infants aged between 7 and 120 days with probable serious bacterial infection: a randomised, double-blind, placebo-controlled trial. Lancet 2012; 379:2072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/85\">",
"      Kikafunda JK, Walker AF, Allan EF, Tumwine JK. Effect of zinc supplementation on growth and body composition of Ugandan preschool children: a randomized, controlled, intervention trial. Am J Clin Nutr 1998; 68:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/86\">",
"      Kabir I, Rahman MM, Haider R, et al. Increased height gain of children fed a high-protein diet during convalescence from shigellosis: a six-month follow-Up study. J Nutr 1998; 128:1688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/87\">",
"      Rivera JA, Ruel MT, Santizo MC, et al. Zinc supplementation improves the growth of stunted rural Guatemalan infants. J Nutr 1998; 128:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/88\">",
"      Castillo-Dur&aacute;n C, Rodr&iacute;guez A, Venegas G, et al. Zinc supplementation and growth of infants born small for gestational age. J Pediatr 1995; 127:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/89\">",
"      Ninh NX, Thissen JP, Collette L, et al. Zinc supplementation increases growth and circulating insulin-like growth factor I (IGF-I) in growth-retarded Vietnamese children. Am J Clin Nutr 1996; 63:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/90\">",
"      Schlesinger L, Arevalo M, Arredondo S, et al. Effect of a zinc-fortified formula on immunocompetence and growth of malnourished infants. Am J Clin Nutr 1992; 56:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/91\">",
"      Brown KH, Peerson JM, Rivera J, Allen LH. Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2002; 75:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/92\">",
"      Hambidge M, Krebs N. Zinc, diarrhea, and pneumonia. J Pediatr 1999; 135:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/93\">",
"      Shankar AH, Genton B, Baisor M, et al. The influence of zinc supplementation on morbidity due to Plasmodium falciparum: a randomized trial in preschool children in Papua New Guinea. Am J Trop Med Hyg 2000; 62:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/94\">",
"      Bates CJ, Evans PH, Dardenne M, et al. A trial of zinc supplementation in young rural Gambian children. Br J Nutr 1993; 69:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/95\">",
"      Sazawal S, Black RE, Ramsan M, et al. Effect of zinc supplementation on mortality in children aged 1-48 months: a community-based randomised placebo-controlled trial. Lancet 2007; 369:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/96\">",
"      Duggan C, MacLeod WB, Krebs NF, et al. Plasma zinc concentrations are depressed during the acute phase response in children with falciparum malaria. J Nutr 2005; 135:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/97\">",
"      Zinc Against Plasmodium Study Group. Effect of zinc on the treatment of Plasmodium falciparum malaria in children: a randomized controlled trial. Am J Clin Nutr 2002; 76:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/98\">",
"      Veenemans J, Milligan P, Prentice AM, et al. Effect of supplementation with zinc and other micronutrients on malaria in Tanzanian children: a randomised trial. PLoS Med 2011; 8:e1001125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/99\">",
"      Evans MF, Frank J. Zinc gluconate lozenges for treating the common cold. Can Fam Physician 1997; 43:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/100\">",
"      Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med 1996; 125:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/101\">",
"      Jackson JL, Peterson C, Lesho E. A meta-analysis of zinc salts lozenges and the common cold. Arch Intern Med 1997; 157:2373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/102\">",
"      Macknin ML, Piedmonte M, Calendine C, et al. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial. JAMA 1998; 279:1962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/103\">",
"      Fosmire GJ. Zinc toxicity. Am J Clin Nutr 1990; 51:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/3/29753/abstract/104\">",
"      Barceloux DG. Zinc. J Toxicol Clin Toxicol 1999; 37:279.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5354 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-122.72.80.101-2F8DE301F2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29753=[""].join("\n");
var outline_f29_3_29753=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28555722\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ZINC METABOLISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ACTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12503302\">",
"      RECOMMENDED INTAKE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ZINC DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Dietary zinc depletion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Acrodermatitis enteropathica",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ZINC SUPPLEMENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Prevention of diarrhea and pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Treatment of acute diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Treatment of persistent diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9661506\">",
"      Adjunctive treatment for bacterial infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28556119\">",
"      Enhancement of growth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Prevention or treatment of malaria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Treatment of the common cold",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      ZINC TOXICITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28555722\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5354\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5354|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/34/40481\" title=\"picture 1\">",
"      Acrodermatitis enteropathica",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/3/4145\" title=\"picture 2\">",
"      Dermatitis zinc defic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5354|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/22/38241\" title=\"table 1\">",
"      DRI trace elements",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/23/29052\" title=\"table 2\">",
"      Dietary sources of zinc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/7/41083\" title=\"table 3\">",
"      Clinical manifestations of zinc deficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/53/19290?source=related_link\">",
"      Acute kidney injury in children: Clinical features, etiology, evaluation, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=related_link\">",
"      Cystic fibrosis: Nutritional issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39226?source=related_link\">",
"      Overview of dietary trace minerals",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/47/41722?source=related_link\">",
"      Overview of the management of Crohn's disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/50/27434?source=related_link\">",
"      Parenteral nutrition in premature infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/37/43609?source=related_link\">",
"      Persistent diarrhea in children in developing countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13146?source=related_link\">",
"      The common cold in children: Treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13338?source=related_link\">",
"      Treatment of severe falciparum malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25241?source=related_link\">",
"      Treatment of uncomplicated falciparum malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=related_link\">",
"      Vegetarian diets for children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_3_29754="Lumbar plexus";
var content_f29_3_29754=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F76701%7ESURG%2F79068&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F76701%7ESURG%2F79068&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lumbar plexus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 430px; height: 411px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The lumbar plexus is formed by the ventral rami of the lumbar nerve roots and supplies the muscular and cutaneous innervation to the lower extremity",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Nerves of the anterior chest and abdomen",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 710px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The chest and abdominal walls are supplied by the thoracic and thoracoabdominal intercostal nerves, as well as nerves from the lumbar plexus. The intercostal nerves arise from the ventral rami of the thoracic spinal nerves from T1 to T11. The corresponding nerve associated with T12 is the subcostal nerve.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29754=[""].join("\n");
var outline_f29_3_29754=null;
var title_f29_3_29755="Dealing with lead paint PI";
var content_f29_3_29755=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F66646&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F66646&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Ways to prevent exposure to lead in paint",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Clean up loose paint chips right away",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wipe off loose paint using damp cloths or rags that you throw away after using",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Block access to chipping paint with furniture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Put contact paper over chipping paint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hose off the porch or put down a blanket or rug where children play",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Seal or block off areas with small amounts of chipping paint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Do NOT use unsafe ways of removing paint:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Do NOT sand off paint without a HEPA attachment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Do NOT burn off paint with an open flame",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Do NOT use chemicals to remove paint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        When hiring contractors to remove lead paint, use only people who are \"certified abatement contractors\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Make sure family and belongings (such as cushioned furniture) are protected during lead removal (called \"abatement\")",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Environmental Protection Agency. Additional information available at:",
"     <a href=\"file://www.epa.gov/lead/\" target=\"_blank\">",
"      file://www.epa.gov/lead/",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29755=[""].join("\n");
var outline_f29_3_29755=null;
var title_f29_3_29756="Sulfonylurea kinetics";
var content_f29_3_29756=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F72580&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F72580&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pharmacokinetics of the sulfonylureas",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Generation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Generic name",
"       </td>",
"       <td class=\"subtitle1\">",
"        Trade name",
"       </td>",
"       <td class=\"subtitle1\">",
"        Time to peak, hours",
"       </td>",
"       <td class=\"subtitle1\">",
"        Half-life, hours",
"       </td>",
"       <td class=\"subtitle1\">",
"        Duration of action, hours",
"       </td>",
"       <td class=\"subtitle1\">",
"        Active metabolites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        First",
"       </td>",
"       <td>",
"        Chlorpropamide",
"       </td>",
"       <td>",
"        Diabinase",
"       </td>",
"       <td>",
"        2-7",
"       </td>",
"       <td>",
"        36",
"       </td>",
"       <td>",
"        24-72",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        First",
"       </td>",
"       <td>",
"        Acetohexamide",
"       </td>",
"       <td>",
"        Dymelor",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        4-6",
"       </td>",
"       <td>",
"        12-18",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        First",
"       </td>",
"       <td>",
"        Tolbutamide",
"       </td>",
"       <td>",
"        Orinase",
"       </td>",
"       <td>",
"        3-4",
"       </td>",
"       <td>",
"        3-28",
"       </td>",
"       <td>",
"        6-12",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        First",
"       </td>",
"       <td>",
"        Tolazamide",
"       </td>",
"       <td>",
"        Tolinase",
"       </td>",
"       <td>",
"        4-6",
"       </td>",
"       <td>",
"        4-8",
"       </td>",
"       <td>",
"        12-24",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Second",
"       </td>",
"       <td>",
"        Glipizide",
"       </td>",
"       <td>",
"        Glucatrol",
"       </td>",
"       <td>",
"        1-3",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        16-24",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Second",
"       </td>",
"       <td>",
"        Glipizide",
"       </td>",
"       <td>",
"        Gucatrol XL",
"       </td>",
"       <td>",
"        6-12",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Second",
"       </td>",
"       <td>",
"        Glyburide",
"       </td>",
"       <td>",
"        <p>",
"         Micronase",
"        </p>",
"        <p>",
"         DiaBeta",
"        </p>",
"        <p>",
"         Glynase",
"        </p>",
"       </td>",
"       <td>",
"        2-6",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        &lt;24",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Third",
"       </td>",
"       <td>",
"        Glimepiride",
"       </td>",
"       <td>",
"        Amaryl",
"       </td>",
"       <td>",
"        2-3",
"       </td>",
"       <td>",
"        5-9",
"       </td>",
"       <td>",
"        16-24",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29756=[""].join("\n");
var outline_f29_3_29756=null;
var title_f29_3_29757="Glycogen metabolism";
var content_f29_3_29757=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F68962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F68962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Glucose metabolism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 296px; height: 330px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the major regulatory steps in hepatic gluconeogenesis (arrows that point upward) and glycolysis (arrows that point downward). The circles with positive or negative signs represent the reactions that are stimulated or inhibited by glucagon. Glucagon promotes gluconeogenesis and blocks glycolysis by decreasing the activity of phosphofructokinase (PFK) and pyruvate kinase (PK). The sites of entry of the gluconeogenetic precursors - glycerol, alanine, and lactate - are shown. Muscle cells lack glucose 6-phosphatase (G6Pase); they can therefore use glycogen for energy but cannot convert it to glucose for release into the systemic circulation. In pancreatic &beta;-cells, glucokinase (GK) may act as the glucose sensor that regulates insulin release.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29757=[""].join("\n");
var outline_f29_3_29757=null;
var title_f29_3_29758="Pain and global activity scales";
var content_f29_3_29758=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F50461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F50461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pain and global activity scales",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 440px; height: 407px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A. Visual analogue scales (VAS) for patient pain assessment, patient global assessment of disease activity and evaluator (physician) global assessment of disease activity. A mark is placed at the presumed level of pain or disease activity between the two ends of a 100 mm line. Vertical lines can also be used as can 11-point numerical scales (0-1-2-3-4-5-6-7-8-9-10 each 1 cm apart) or (B) Likert scales.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29758=[""].join("\n");
var outline_f29_3_29758=null;
var title_f29_3_29759="Zanca view radiograph of AC joint";
var content_f29_3_29759=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F82477&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F82477&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Zanca view radiograph of AC joint",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 277px; height: 514px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The x-ray of the acromioclavicular joint using the Zanca view (bottom image) provides a clearer view of the joint, without overlapping bone, compared to a standard AP view of the shoulder (top image).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Scott Koehler, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_3_29759=[""].join("\n");
var outline_f29_3_29759=null;
